{"study_id": 110714, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of arachidonic acid in psoriasis pathogenesis and explore the therapeutic potential of omega-3 fatty acids (EPA and DHA) in mitigating its proinflammatory effects.", "results_summary": "The study found that arachidonic acid contributes to psoriasis by generating proinflammatory mediators, while omega-3 fatty acids (EPA and DHA) inhibit these mediators and promote resolution of inflammation through resolvins and protectins. However, challenges like instability and poor bioavailability limit their effectiveness, prompting interest in nanomedicine for improved delivery.", "population_specificity": "Patients with psoriasis (autoimmune skin disorder).", "effective_dosage": "Dose-dependent manner (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:51.079579+00:00"}
{"study_id": 110713, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omeprazole affects the pharmacokinetic and pharmacodynamic behavior of aspirin (ASA) and extended-release dipyridamole (ER-DP), particularly focusing on ASA's inhibition of arachidonic acid-induced platelet aggregation.", "results_summary": "The study found no significant effect of omeprazole on the systemic exposure to ER-DP or the inhibition of arachidonic acid-induced platelet aggregation by ASA, with nearly identical results between treatments with and without omeprazole.", "population_specificity": "60 healthy male and female volunteers aged 18-50 years.", "effective_dosage": "ASA+ER-DP 25 mg/200 mg twice daily; omeprazole 80 mg once daily.", "study_duration": "Four 7-day treatment periods with washout periods of \u226514 days.", "interactions": "None mentioned between arachidonic acid and other substances; the study focused on ASA+ER-DP and omeprazole interaction.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:51.501879+00:00"}
{"study_id": 110715, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the pharmacodynamic profile of urocortins 2 and 3 and examine the role of the endothelium, including cytochrome P450 metabolites of arachidonic acid, in mediating their vasomotor effects in healthy humans.", "results_summary": "The study found that urocortins 2 and 3 caused potent and prolonged arterial vasodilation, partly mediated by endothelial nitric oxide and cytochrome P450 metabolites of arachidonic acid. Inhibition of these pathways attenuated vasodilation, suggesting a role for arachidonic acid metabolites in the vasomotor response.", "population_specificity": "18 healthy male volunteers (23\u00b14 years)", "effective_dosage": "Not specified for arachidonic acid (fluconazole was used to inhibit cytochrome P450 metabolites of arachidonic acid)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:52.052296+00:00"}
{"study_id": 110717, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid as an inflammatory mediator in Kounis syndrome and its potential therapeutic implications.", "results_summary": "Arachidonic acid was identified as one of the inflammatory mediators released during mast-cell activation in Kounis syndrome, contributing to acute coronary events. The study suggests that inhibiting mast-cell degranulation, which involves arachidonic acid products, may prevent such events.", "population_specificity": "Patients with Kounis syndrome (allergic angina, allergic myocardial infarction, or stent thrombosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:53.430037+00:00"}
{"study_id": 110718, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived Lipoxin A4 (LXA4) in endometrial function, including its potential anti-inflammatory and immunomodulatory effects.", "results_summary": "The study found that LXA4, synthesized from arachidonic acid, acts as an estrogen receptor agonist in endometrial epithelial cells and may have anti-inflammatory properties in the endometrium, with potential implications for conditions like endometriosis.", "population_specificity": "Female reproductive tract, particularly endometrial tissue.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:54.559650+00:00"}
{"study_id": 110716, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of n-3 to n-6 PUFA ratios, specifically focusing on arachidonic acid (AA), on coronary atherosclerosis progression in patients treated with pitavastatin or pravastatin.", "results_summary": "The study found that decreases in n-3 to n-6 PUFA ratios (DHA/AA and EPA+DHA/AA) were associated with coronary atherosclerosis progression during pravastatin therapy but not during pitavastatin therapy. Multivariate analysis identified changes in the DHA/AA ratio as a significant predictor of plaque volume changes in pravastatin-treated patients.", "population_specificity": "101 patients with coronary atherosclerosis undergoing percutaneous coronary intervention, divided into pitavastatin (51) and pravastatin (50) treatment groups.", "effective_dosage": "Not specified", "study_duration": "8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:55.079502+00:00"}
{"study_id": 110719, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of hGIIA in tumor growth and inflammation, particularly its non-catalytic signaling pathway involving arachidonic acid metabolism.", "results_summary": "The study found that hGIIA signaling can be selectively inhibited over its catalytic activity, with inhibitors disrupting vimentin localization and suggesting a link between hGIIA, vimentin, and arachidonic acid metabolism in synovial inflammation.", "population_specificity": "Rheumatoid fibroblast-like synoviocytes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:55.472493+00:00"}
{"study_id": 110722, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of aberrant arachidonic acid metabolites in the molecular pathogenesis of colorectal cancer risk in inflammatory bowel disease (IBD).", "results_summary": "The study identified aberrant arachidonic acid metabolites as one of the molecular events contributing to chronic inflammation and cancer progression in IBD, but did not quantify its specific effects or efficacy.", "population_specificity": "Patients with inflammatory bowel disease (IBD) at risk for colorectal cancer.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.079783+00:00"}
{"study_id": 110721, "supplement_id": 885, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the efficacy and safety of a low-dose aspirin desensitization protocol (100 mg daily) in preventing nasal polyp recurrence and improving quality of life in individuals with AERD.", "results_summary": "The study found that low-dose aspirin desensitization reduced nasal polyp relapse, improved quality of life, and significantly reduced clinical complaints without severe side effects, though statistical significance for polyp relapse was marginal (P = 0.0785).", "population_specificity": "70 individuals with aspirin-exacerbated respiratory disease (AERD) who underwent sinus surgery (only 31 evaluated due to high dropout rate).", "effective_dosage": "100 mg daily", "study_duration": "36 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.504207+00:00"}
{"study_id": 110723, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review advances in understanding the enzymes and pathways involved in the metabolism of arachidonic acid-derived endocannabinoids, focusing on their potential as therapeutic targets.", "results_summary": "The study highlights the biosynthesis and degradation pathways of arachidonic acid-derived endocannabinoids, identifying new enzymes and pathways that may serve as novel therapeutic targets, such as selective inhibitors for anti-inflammatory and analgesic drugs.", "population_specificity": "Mammals (general, not human-specific)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.624020+00:00"}
{"study_id": 110720, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of \u03c9-3 PUFA supplementation on intracellular phospholipase A2 (inPLA(2)) activity and peripheral membrane lipid profiles, including arachidonic acid, in individuals at ultra-high risk (UHR) for psychosis.", "results_summary": "The study found that \u03c9-3 PUFA supplementation significantly decreased inPLA(2) activity and influenced membrane lipid profiles, with arachidonic acid showing opposite correlations with inPLA(2) activity in those who did or did not transition to psychosis.", "population_specificity": "Young people at ultra-high risk (UHR) of transition to psychosis (n=80 cross-sectionally, n=65 longitudinally).", "effective_dosage": "1.2 g per day \u03c9-3 PUFAs.", "study_duration": "12-week intervention followed by a 40-week observation period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.803243+00:00"}
{"study_id": 110724, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the crosstalk within the ARA cascade pathways and evaluate multitarget inhibition as a strategy to enhance efficacy or reduce side-effects in treating inflammation and pain.", "results_summary": "The study highlights that pharmacological inhibition of a single ARA cascade pathway can disrupt oxylipin levels, posing risks, and suggests that multitarget inhibition may offer improved efficacy and reduced side-effects for inflammation and pain treatment.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:01.270993+00:00"}
{"study_id": 110725, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether low-dose aspirin could attenuate platelet activation, including responses to arachidonic acid, in HIV-1-infected adults on antiretroviral therapy.", "results_summary": "The study found that HIV-1-infected subjects had elevated platelet aggregation in response to arachidonic acid, which remained elevated after aspirin therapy, unlike responses to other agonists. Aspirin reduced other markers of immune activation.", "population_specificity": "HIV-1-infected adults virologically suppressed on antiretroviral therapy and healthy controls.", "effective_dosage": "Low-dose aspirin (specific dosage not mentioned in abstract).", "study_duration": "1 week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:02.700203+00:00"}
{"study_id": 110726, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of 12/15-LOX, a key enzyme in the arachidonic acid cascade, in neuronal cell death and vascular injury, and its potential as a therapeutic target for ischemic stroke.", "results_summary": "The study suggests that inhibition of 12/15-LOX may provide multifactorial protection against ischemic injury by targeting both neuronal cell death and vascular injury pathways. The abstract highlights the potential of 12/15-LOX and related eicosanoid pathways as novel drug targets for stroke therapy.", "population_specificity": "Not specified (abstract focuses on general mechanisms rather than a specific population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:03.153509+00:00"}
{"study_id": 110727, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the interactions between the cyclooxygenase (COX) and nitric oxide synthase (NOS) pathways, particularly how nitric oxide (NO) influences COX-mediated conversion of arachidonic acid to prostaglandins and related compounds.", "results_summary": "The study found that NO activates COX enzymes, increasing prostaglandin production, and highlighted the role of COX as a modulator of NO's effects in physiological and pathological processes. Emerging evidence also suggests nitroxidative species may influence prostaglandin biosynthesis through non-COX pathways.", "population_specificity": "Not specified (in vitro and in vivo studies, no human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:04.382395+00:00"}
{"study_id": 110729, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of different doses of farmed Atlantic salmon on plasma phospholipid fatty acid proportions, including arachidonic acid, and CVD risk biomarkers in healthy subjects.", "results_summary": "The study found that arachidonic acid and total n-6 fatty acids decreased dose-dependently with salmon consumption, while n-3 fatty acids increased. These changes were associated with decreased CVD risk.", "population_specificity": "19 apparently healthy men and women, aged 40-65 years, with a BMI between 25-34.9.", "effective_dosage": "90 g, 180 g, and 270 g of farmed Atlantic salmon twice per week.", "study_duration": "4 weeks per treatment period, with 4- to 8-week washout periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.783648+00:00"}
{"study_id": 110728, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to compare the antiplatelet effects of spaced administration of PA32540 (aspirin + immediate-release omeprazole) and clopidogrel versus synchronous administration of clopidogrel, EC aspirin, and EC omeprazole, focusing on arachidonic acid-induced aggregation.", "results_summary": "The study found no difference in arachidonic acid-induced platelet aggregation between the two treatment regimens, though spaced PA32540 + clopidogrel showed greater overall antiplatelet effects. The effect was independent of CYP2C19 and ABCB1 genotypes.", "population_specificity": "Healthy volunteers (n = 30)", "effective_dosage": "PA32540 (aspirin 81 mg + omeprazole) + clopidogrel (300 mg loading/75 mg maintenance)", "study_duration": "7-day treatments separated by 14-day washout periods", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.960694+00:00"}
{"study_id": 110730, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the contribution of cytochrome P450 (CYP) metabolites of arachidonic acid, specifically 20-HETE and EETs, to renal microvascular function and their potential therapeutic roles in hypertension.", "results_summary": "The study found that 20-HETE constricts afferent arterioles and contributes to pro-hypertensive effects, while EETs act as anti-hypertensive factors by activating renal microvascular smooth muscle cell channels. Initial genetic and experimental studies with inhibitors and analogs demonstrated improved renal microvascular function in hypertension.", "population_specificity": "Renal microvasculature (animal or in vitro models, not explicitly stated for humans).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:09.324121+00:00"}
{"study_id": 110731, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate methods for lowering dietary n-6 PUFA (including arachidonic acid) while maintaining or increasing n-3 PUFA intake and validate these methods through dietary recalls and erythrocyte fatty acid analyses.", "results_summary": "The study successfully reduced dietary linoleic acid (LA) to \u22642.5% of energy in both intervention groups, with the high-n-3 group also achieving targeted increases in ALA and EPA+DHA. Dietary changes were confirmed by corresponding erythrocyte fatty acid composition changes.", "population_specificity": "Sixty-seven randomized subjects in an outpatient clinical trial setting.", "effective_dosage": "Arachidonic acid intake was targeted at \u226460 mg/day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:09.939992+00:00"}
{"study_id": 110734, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the patent activity and development of EP receptor modulators targeting prostaglandin E(2) receptors, including their potential applications beyond classical indications like pain and inflammation.", "results_summary": "The study highlights the development of potent and selective EP receptor modulators but notes that their pharmacological utility and clinical use require further investigation. Novel methods for using these modulators have been explored, though their efficacy and safety profiles remain understudied.", "population_specificity": "Not specified (focus on patent activity and preclinical/industrial research).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.097739+00:00"}
{"study_id": 110732, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of statins (pitavastatin and pravastatin) on the serum levels of arachidonic acid (AA) and its ratios with other PUFAs in patients with coronary artery disease.", "results_summary": "Pitavastatin, but not pravastatin, significantly decreased the DHA/AA ratio and showed correlations between changes in LDL cholesterol and AA levels. The EPA/AA ratio remained unchanged in both groups.", "population_specificity": "101 patients with coronary artery disease not receiving lipid-lowering therapy.", "effective_dosage": "4 mg/day pitavastatin or 20 mg/day pravastatin.", "study_duration": "8 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.337258+00:00"}
{"study_id": 110733, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare PlateletMapping\u00ae and VerifyNow\u00ae for detecting aspirin resistance, including assessing the role of arachidonic acid in confirming aspirin compliance.", "results_summary": "Arachidonic acid was used to confirm aspirin compliance, showing <20% aggregation response in compliant patients. Aspirin-resistant patients had higher urinary thromboxane levels, but arachidonic acid itself was not directly evaluated for efficacy beyond compliance testing.", "population_specificity": "200 patients undergoing invasive cardiac procedures, including 10 not receiving aspirin therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Significant increased aspirin sensitivity with clopidogrel or statin cotherapies; smoking correlated with aspirin resistance.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.632711+00:00"}
{"study_id": 110735, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of TLR activation in tumor progression, including its potential interaction with mediators of inflammation such as the arachidonic acid signaling pathways.", "results_summary": "The abstract suggests that TLR activation upregulates protumorigenic pathways, potentially involving arachidonic acid signaling, but does not provide specific findings on arachidonic acid's direct effects.", "population_specificity": "Not specified (general discussion of tumor microenvironment and human tumors).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:12.122308+00:00"}
{"study_id": 110738, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential role of arachidonic acid metabolites in the neurobiology of opioid withdrawal syndrome.", "results_summary": "The abstract suggests that arachidonic acid metabolites may contribute to the mechanisms of opioid withdrawal syndrome, but no specific findings on their effects are detailed.", "population_specificity": "Animal models (in vivo and in vitro) of opioid withdrawal syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.894000+00:00"}
{"study_id": 110736, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanisms and effects of nitro-fatty acids, particularly nitroarachidonic acid, on inflammatory signaling pathways and their potential as pharmacological tools for inflammatory diseases.", "results_summary": "Nitro-fatty acids, including nitroarachidonic acid, modulate inflammatory and metabolic signaling pathways, activate antioxidant responses, and redirect arachidonic acid metabolism, showing promise for preventing inflammatory diseases linked to oxidative stress.", "population_specificity": "Not specified (general human plasma, cell membranes, and tissue studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.865254+00:00"}
{"study_id": 110737, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolism dysregulation in the pathogenesis of Aspirin Exacerbated Respiratory Disease (AERD).", "results_summary": "The study found that AERD involves dysregulated arachidonic acid metabolism, including reduced PGE2 synthesis, increased PGD2 production, and overproduction of cysteinyl leukotrienes, contributing to bronchoconstriction and inflammation. NSAID intake exacerbates these effects, worsening asthma symptoms.", "population_specificity": "Patients with Aspirin Exacerbated Respiratory Disease (AERD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "NSAIDs exacerbate bronchoconstriction and inflammation in AERD patients.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:17.556086+00:00"}
{"study_id": 110742, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of n-3 PUFA-supplementation on platelet aggregation, including arachidonic acid-induced aggregation.", "results_summary": "The study found a non-significant trend toward decreased arachidonic acid-induced platelet aggregation (SMD = -0.43, p = 0.64), but statistical significance was not reached.", "population_specificity": "High-risk patients with cardiovascular disease and diabetics, as well as healthy persons.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.070503+00:00"}
{"study_id": 110741, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of EPA supplementation on biological risk factors, including arachidonic acid (AA) levels, in diabetic patients with comorbid major depressive disorder.", "results_summary": "EPA supplementation decreased plasma arachidonic acid concentrations but had limited overall effects on other biological risk factors. The study observed mixed results, with some changes in HPA-axis reactivity and lipoprotein concentrations.", "population_specificity": "Patients with diabetes mellitus and comorbid major depressive disorder (n = 25).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.099219+00:00"}
{"study_id": 110743, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of ACSL1 in promoting C20:4 (arachidonic acid) metabolism and its inflammatory and proatherosclerotic effects in diabetic monocytes/macrophages.", "results_summary": "The study found that ACSL1 upregulation in diabetic monocytes/macrophages promotes arachidonic acid metabolism, contributing to inflammation and atherosclerosis, and that ACSL1 inhibition selectively protects these cells from these effects.", "population_specificity": "Diabetic mice and humans with type 1 diabetes.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.633609+00:00"}
{"study_id": 110739, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the interaction between aspirin and other COX inhibitors (NSAIDs) in relation to arachidonic acid's role in platelet COX-1 inhibition.", "results_summary": "The study found that some NSAIDs (e.g., ibuprofen, dipyrone) competitively inhibit arachidonic acid binding to COX-1, reducing aspirin's antiplatelet effects, while others (e.g., diclofenac, acetaminophen) do not. This interaction may increase cardiovascular risk in patients requiring chronic antiplatelet therapy.", "population_specificity": "Healthy subjects and patients with chronic inflammation (e.g., rheumatoid arthritis).", "effective_dosage": "Not specified for arachidonic acid; aspirin dosage mentioned (75-325 mg/day).", "study_duration": "Not specified.", "interactions": "Competitive inhibition with ibuprofen and dipyrone; no interaction with diclofenac or acetaminophen.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:20.271563+00:00"}
{"study_id": 110740, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether alpha-lipoic acid (\u03b1-LA) could reduce oxidative stress in ACS patients by modulating ALDH2 activity and arachidonic acid metabolism (measured via 8-iso-PGF2\u03b1 levels).", "results_summary": "The study found that \u03b1-LA significantly increased ALDH2 activity and decreased 8-iso-PGF2\u03b1 levels (a marker of oxidative stress derived from arachidonic acid) in ACS patients, with a strong correlation between these effects.", "population_specificity": "63 patients (52 men, 11 women, aged 49\u201372) with confirmed acute coronary syndrome (ACS).", "effective_dosage": "600 mg \u03b1-LA intravenously daily.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:20.279404+00:00"}
{"study_id": 110744, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid (AA) in linking the endocannabinoid and eicosanoid systems and its therapeutic potential via MAGL inhibition in diseases like neurodegeneration and cancer.", "results_summary": "The study found that MAGL inhibitors, which regulate AA production, exhibit anti-inflammatory, neuroprotective, and anti-cancer effects by modulating lipid signaling pathways. These inhibitors also enhance endocannabinoid signaling, reducing symptoms like pain, anxiety, and withdrawal in addiction models.", "population_specificity": "Mouse models and specific tissues in disease contexts (neurodegeneration, cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.349751+00:00"}
{"study_id": 110746, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of arachidonic acid in activating atypical PKC (PKC\u03b6) and its involvement in cell motility, particularly in cancer and hematopoietic cells.", "results_summary": "The study found that arachidonic acid is one of the lipid components that can activate PKC\u03b6, which plays a crucial role in cell motility, polarization, and cancer cell migration. Atypical PKC, including PKC\u03b6, is essential for the regulation of hematopoietic cell motility and proteolytic activity in podosomes and invadopodia.", "population_specificity": "Cancer cells and hematopoietic cells (specific human or animal models not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:26.219735+00:00"}
{"study_id": 110747, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to review the mechanisms of platelet-mediated thrombosis and the role of arachidonic acid pathway inhibition in improving outcomes for acute coronary syndromes (ACS).", "results_summary": "The study highlights that aspirin, by inhibiting the COX-1 enzyme in the arachidonic acid pathway, improves patient outcomes in ACS. Other agents like thienopyridines and glycoprotein IIb/IIIa inhibitors further enhance platelet inhibition, with varying efficacy and safety profiles.", "population_specificity": "Patients with acute coronary syndromes (ACS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.391418+00:00"}
{"study_id": 110750, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of 20-HETE, a metabolite of arachidonic acid, in sepsis and septic shock, and evaluate the potential of synthetic 20-HETE analogs as a treatment.", "results_summary": "The study found that a synthetic 20-HETE analog prevented endotoxin-induced vascular hyporeactivity, hypotension, and mortality in a rodent model of septic shock by modulating nitric oxide and prostanoid pathways. It also highlighted 20-HETE as a proinflammatory mediator in endotoxin-induced systemic inflammation.", "population_specificity": "Rodent model of septic shock", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:28.290165+00:00"}
{"study_id": 110748, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to compare the biological efficacy of aspirin administered once daily versus twice daily in diabetic patients with coronary artery disease, focusing on platelet reactivity to arachidonic acid.", "results_summary": "Twice-daily aspirin significantly reduced platelet reactivity to arachidonic acid compared to once-daily administration, with lower rates of biological resistance observed. The improvement was consistent across multiple measures of platelet function.", "population_specificity": "Diabetic patients with previous coronary artery disease and at least one criterion of time-dependent aspirin efficacy (elevated hs-CRP, fibrinogen, platelet count, or active smoking).", "effective_dosage": "150 mg aspirin daily (either 150 mg once in the morning or 75 mg twice daily).", "study_duration": "Crossover study design (specific duration not mentioned in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:28.634716+00:00"}
{"study_id": 110749, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the correlations between the n-3 to n-6 polyunsaturated fatty acid ratio (specifically EPA/AA, DHA/AA, and EPA+DHA/AA) and coronary atherosclerosis progression or regression.", "results_summary": "The study found significant negative correlations between changes in the EPA/AA, DHA/AA, and EPA+DHA/AA ratios and changes in plaque volume and fibrous component volume, indicating that lower ratios (higher AA relative to n-3 fatty acids) were associated with atherosclerosis progression. Multivariate analysis confirmed that changes in the EPA+DHA/AA ratio were significant predictors of plaque and fibrous component volume changes.", "population_specificity": "101 statin-treated patients with coronary artery disease undergoing percutaneous coronary intervention.", "effective_dosage": "Not specified", "study_duration": "8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:28.830487+00:00"}
{"study_id": 110751, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid-derived epoxyeicosatrienoic acids (EETs) in vascular function and their potential as a pharmacological target for cardiovascular diseases.", "results_summary": "The study found that EETs, derived from arachidonic acid, play a key role in flow-mediated dilation in healthy subjects and are impaired in hypertensive patients. Inhibiting soluble epoxide hydrolase (sEH) to restore EET availability showed promising results in reducing blood pressure and organ damage in animal models, with a first product entering clinical evaluation.", "population_specificity": "Healthy subjects and essential hypertensive patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:29.183365+00:00"}
{"study_id": 110752, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether arachidonic acid (AA) and its ratio with eicosapentaenoic acid (EPA) were predictive factors for ischemic stroke and its subtypes.", "results_summary": "The study found that a lower EPA/AA ratio was a significant risk factor for cardioembolism, a subtype of ischemic stroke, but large-artery atherosclerosis was not related to AA or the EPA/AA ratio.", "population_specificity": "65 patients with ischemic stroke and 65 control subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.490290+00:00"}
{"study_id": 110753, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid derivatives in Wallerian degeneration and nerve regeneration, and their potential therapeutic applications.", "results_summary": "The study found that arachidonic acid derivatives, such as prostaglandins and leukotrienes, mediate neuroimmune signaling during nerve degeneration and regeneration, suggesting their involvement in the process and potential therapeutic opportunities.", "population_specificity": "Not specified (focus on molecular and cellular mechanisms in nerve injury models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:33.975530+00:00"}
{"study_id": 110756, "supplement_id": 885, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether high dietary intake of linoleic acid (LA), which influences arachidonic acid metabolism, contributes to chronic inflammation by altering inflammatory markers.", "results_summary": "The study found no significant increase in inflammatory markers with higher LA intake, except for minor changes in specific eicosanoid excretions, which were not linked to increased inflammation. The authors concluded that LA does not promote chronic inflammation in healthy populations.", "population_specificity": "Healthy, noninfant human beings", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:35.999536+00:00"}
{"study_id": 110754, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess whether postnatal fish oil supplementation (affecting arachidonic acid levels) could prevent allergic diseases in high-risk infants.", "results_summary": "Fish oil supplementation increased infant n-3 PUFA levels and reduced erythrocyte arachidonic acid levels, but did not significantly prevent allergic outcomes like eczema, asthma, or food allergy.", "population_specificity": "Infants at high atopic risk, from birth to 6 months of age.", "effective_dosage": "Daily supplement containing 280 mg docosahexaenoic acid and 110 mg eicosapentaenoic acid.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:36.410121+00:00"}
{"study_id": 110745, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess whether arachidonic acid (AA) added prognostic information for predicting mortality and cardiac events in patients with acute coronary syndrome (ACS).", "results_summary": "The study found that AA provided no additional prognostic information for predicting fatal events in patients with suspected ACS. Event rates were similar across all quartiles of the omega-3 index, and AA did not influence outcomes.", "population_specificity": "572 patients (median age 63, 59% male) admitted with chest pain and suspected ACS in a Northern Argentinean city with a diet high in red meat and low in fish.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 3.6 years (range 1 day to 5.5 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:36.436950+00:00"}
{"study_id": 110757, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the physiological effects of arachidonic acid-derived prostacyclin (PGI\u2082), particularly its role in cardiovascular health and immunomodulation.", "results_summary": "The study found that PGI\u2082, derived from arachidonic acid, has potent vasodilatory and anti-platelet aggregation effects, supporting its use in treating pulmonary arterial hypertension (PAH). Additionally, PGI\u2082 exhibits anti-inflammatory and immunosuppressive properties, suggesting broader immunomodulatory applications.", "population_specificity": "Not specified (broad physiological effects across cell types).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.050985+00:00"}
{"study_id": 110758, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess platelet reactivity to arachidonic acid in patients with acute coronary syndromes (ACS) undergoing PCI and determine resistance to acetylsalicylic acid.", "results_summary": "The study found a low rate of acetylsalicylic acid resistance (8.3%) based on arachidonic acid-induced platelet aggregation, indicating effective platelet inhibition in most patients. No association was found between genetic polymorphisms and resistance.", "population_specificity": "60 Mexican patients with ACS undergoing emergent PCI.", "effective_dosage": "300 mg acetylsalicylic acid loading dose.", "study_duration": "Platelet aggregation assessed at 24 hours post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.987503+00:00"}
{"study_id": 110759, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between aspirin resistance (measured via response to arachidonic acid and adenosine diphosphate) and chronic renal failure in patients with coronary artery disease.", "results_summary": "The study found that aspirin resistance, defined by response to arachidonic acid, was associated with lower estimated glomerular filtration rates, indicating a weak relationship between worsening renal function and aspirin resistance. Arachidonic acid-stimulated platelet CD62P expression also inversely correlated with renal function.", "population_specificity": "169 stable outpatients with proven coronary artery disease (myocardial infarction, coronary artery bypass grafting, intra-coronary stents) taking 75 mg aspirin daily.", "effective_dosage": "0.5 mg/mL arachidonic acid (agonist concentration for aggregometry).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:39.944880+00:00"}
{"study_id": 110760, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of postnatal fish oil supplementation on infant immune function and allergic disease, including the impact on arachidonic acid (AA) levels.", "results_summary": "The study found that fish oil supplementation lowered erythrocyte arachidonic acid (AA) levels and was associated with reduced Th2 responses to allergens and elevated Th1 responses, suggesting immunomodulatory effects.", "population_specificity": "Infants at high risk of atopic disease.", "effective_dosage": "280 mg DHA and 110 mg EPA daily.", "study_duration": "From birth to 6 months of age.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.269716+00:00"}
{"study_id": 110761, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived leukotrienes in the pathogenesis of systemic sclerosis (SSc) and assess the potential of leukotriene pathway blockade as a treatment.", "results_summary": "The study suggests that excessive leukotriene synthesis, derived from arachidonic acid, may contribute to the development and progression of SSc by influencing inflammation, vascular function, and connective tissue remodeling. Blocking leukotriene pathways appears promising for treating SSc.", "population_specificity": "Patients with systemic sclerosis (SSc, scleroderma).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.422749+00:00"}
{"study_id": 110762, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived eicosanoids and adipokines in breast cancer, focusing on their molecular mechanisms and clinical implications related to inflammation.", "results_summary": "The study highlights that arachidonic acid-derived prostaglandins and reactive oxygen species (ROS)-catalyzed eicosanoids are involved in chronic inflammation, which is linked to breast cancer. However, the specific characteristics of these compounds in breast cancer remain less demonstrated.", "population_specificity": "Postmenopausal women with risk factors such as weight gain, obesity, and estrogen secretion.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:44.635081+00:00"}
{"study_id": 110764, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of acetyl salicylic acid on arachidonic acid-induced platelet aggregation in children with systemic-to-pulmonary shunts.", "results_summary": "Acetyl salicylic acid reduced arachidonic acid-induced platelet aggregation in most patients, with 93% achieving the therapeutic range 5 hours post-dose, though efficacy declined over time (64% after 3\u20136 months).", "population_specificity": "Pediatric patients (median age 12 days, range 3\u2013100 days) with systemic-to-pulmonary shunts.", "effective_dosage": "3\u20135 mg/kg once daily (oral acetyl salicylic acid).", "study_duration": "3\u20136 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:45.200692+00:00"}
{"study_id": 110766, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review structure-based drug design strategies for developing novel 5-LOX inhibitors targeting arachidonic acid metabolism to treat inflammatory disorders.", "results_summary": "The abstract highlights the role of 5-LOX in metabolizing arachidonic acid to produce leukotrienes involved in inflammatory diseases and cancer, and discusses the application of computer-aided drug design (CADD) in developing 5-LOX inhibitors like Zileuton for asthma treatment.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:46.063736+00:00"}
{"study_id": 110763, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the influence of pantoprazole on the antiplatelet effect of clopidogrel, including the role of arachidonic acid in platelet aggregation.", "results_summary": "The study found no statistically significant differences in maximal aggregation values with arachidonic acid stimulus between the pantoprazole and ranitidine groups at both time points. Arachidonic acid's effects were consistent and not influenced by pantoprazole.", "population_specificity": "105 patients with ST elevation myocardial infarction (STEMI) treated with percutaneous coronary angioplasty (PCI) and dual antiplatelet therapy.", "effective_dosage": "1 mM arachidonic acid (concentration used in aggregometry).", "study_duration": "Evaluated at 5 (T0) and 30 (T1) days after PCI.", "interactions": "None mentioned for arachidonic acid specifically.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:46.959754+00:00"}
{"study_id": 110765, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effect of pioglitazone therapy on plasma 15-epi-LXA(4) levels in patients with type 2 diabetes.", "results_summary": "Pioglitazone therapy increased plasma 15-epi-LXA(4) and adiponectin levels while reducing fasting plasma glucose, free fatty acids, and HOMA-IR. Higher doses (30 mg/day) showed greater improvements in adiponectin, HbA1c, and HOMA-IR but also increased body weight.", "population_specificity": "Patients with type 2 diabetes (Age = 56 \u00b1 2 y, BMI = 33 \u00b1 1.8, HbA1c = 7.8 \u00b1 0.3%) not on thiazolidinedione therapy for at least 12 months.", "effective_dosage": "15 mg/day for two months or 15 mg/day for one month followed by 30 mg/day for an additional month.", "study_duration": "Two months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:48.368919+00:00"}
{"study_id": 110767, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of cPLA2 in generating arachidonic acid and its involvement in the pathogenesis of Alzheimer's disease (AD).", "results_summary": "The study highlights that cPLA2 is a key molecule in the neurodegenerative mechanisms of AD, linking arachidonic acid production to inflammation and lipid metabolism alterations in AD brains. Findings from in vitro studies, animal models, and human brain imaging support this connection.", "population_specificity": "Primarily focused on Alzheimer's disease models, including in vitro studies, animal models, and human brain imaging.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:48.641292+00:00"}
{"study_id": 110768, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the pharmacodynamic effects of prasugrel, including its inhibition of arachidonic acid-induced platelet aggregation, under systemic inflammation conditions.", "results_summary": "Prasugrel significantly reduced arachidonic acid-induced platelet aggregation by 60%, demonstrating its broad inhibitory effects on multiple platelet aggregation pathways. However, von Willebrand Factor release during endotoxaemia partially counteracted prasugrel's inhibitory effects under high-shear conditions.", "population_specificity": "20 healthy male volunteers", "effective_dosage": "60 mg loading dose of prasugrel", "study_duration": "2 hours before endotoxin or placebo infusion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:53.073002+00:00"}
{"study_id": 110770, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of inflammation, particularly involving arachidonic acid-derived prostaglandins, in the pathogenesis of cutaneous malignant melanoma and explore potential therapeutic targets.", "results_summary": "The study highlights that arachidonic acid-derived prostaglandins contribute to tumor development and progression, and COX inhibitors (including NSAIDs) show anti-tumorigenic effects by inhibiting prostaglandin formation and altering gene expression. The focus is on malignant melanoma, where inflammation plays a significant role in its rapid progression and poor treatment response.", "population_specificity": "Research primarily addresses cutaneous malignant melanoma, a prevalent and aggressive skin cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:53.376662+00:00"}
{"study_id": 110769, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the antiplatelet activity and safety of combined indobufen and clopidogrel treatment in ACS patients with aspirin hypersensitivity undergoing coronary stenting, focusing on platelet aggregation responses to arachidonic acid.", "results_summary": "The study found significantly lower platelet aggregation to arachidonic acid in the group receiving indobufen plus clopidogrel compared to clopidogrel alone, indicating effective inhibition. Serum thromboxane B2 levels were very low in the indobufen group, suggesting strong suppression of arachidonic acid pathways.", "population_specificity": "Acute coronary syndrome (ACS) patients with aspirin hypersensitivity undergoing coronary stenting.", "effective_dosage": "Indobufen 100 mg twice daily; clopidogrel 75 mg daily (300 mg loading dose).", "study_duration": "18 months (monitored at 1, 3, 6, 12, and 18 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:53.425822+00:00"}
{"study_id": 110773, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid (AA) in detecting aspirin resistance and its association with genetic polymorphisms in Chinese patients.", "results_summary": "TEG-AA was more sensitive, specific, and consistent than P-selectin in detecting aspirin resistance, and the PTGS2 G765C mutation was linked to higher aspirin resistance.", "population_specificity": "360 aspirin-treated Chinese patients and 314 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:54.531847+00:00"}
{"study_id": 110771, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolites in the pathophysiology of aspirin-intolerant asthma (AIA) and their potential as biomarkers.", "results_summary": "The study found that AIA patients had higher baseline urinary concentrations of leukotriene E(4) and a PGD(2) metabolite, suggesting increased mast cell activation, and lower levels of anti-inflammatory mediators, indicating impaired anti-inflammatory responses. During AIA reactions, these metabolites increased significantly, further implicating mast cell activation in the condition.", "population_specificity": "Patients with aspirin-intolerant asthma (AIA).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:54.666273+00:00"}
{"study_id": 110772, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid (ARA) in rheumatoid arthritis (RA) and the potential benefits of marine n-3 PUFAs (EPA and DHA) in modulating ARA metabolism and inflammation.", "results_summary": "The study found that marine n-3 PUFAs reduce ARA content in immune cells and decrease inflammatory eicosanoid production, leading to modest improvements in RA symptoms such as joint swelling, pain, and morning stiffness. However, the effects were inconsistent across immune and inflammatory markers.", "population_specificity": "Patients with rheumatoid arthritis (RA).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:55.293904+00:00"}
{"study_id": 110775, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to investigate platelet activity, including arachidonic acid-induced aggregation, in ACS patients at a three-month follow-up to assess persistent high on-treatment platelet reactivity.", "results_summary": "The study found no significant percentage change in platelet aggregation induced by arachidonic acid at the three-month follow-up in ACS patients on aspirin therapy, indicating persistent high platelet reactivity.", "population_specificity": "124 patients (65 with ACS, 59 controls with non-cardiac chest pain); 25 ACS patients returned for follow-up.", "effective_dosage": "Not specified", "study_duration": "Three months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:57.006038+00:00"}
{"study_id": 110774, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspirin enhances platelet isoprostanes, derived from arachidonic acid oxidation, in type 2 diabetes mellitus (T2DM) patients.", "results_summary": "The study found that aspirin-treated T2DM patients had higher platelet isoprostane levels and NOX2 activation, which mitigated aspirin's inhibition of thromboxane A2, suggesting oxidative stress-mediated platelet overproduction.", "population_specificity": "Type 2 diabetes mellitus (T2DM) patients and nondiabetic controls, matched for age, sex, and atherosclerosis risk factors.", "effective_dosage": "100 mg/day aspirin", "study_duration": "7 days (short-term intervention)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:58.825158+00:00"}
{"study_id": 110777, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of PLA2 enzymes, particularly in generating arachidonic acid, and their involvement in inflammatory metabolic diseases like diabetes and atherosclerosis.", "results_summary": "The study found that PLA2 enzymes, including cPLA2\u03b1 and iPLA2, generate arachidonic acid, which activates leukocyte chemotactic responses and promotes inflammatory metabolic diseases such as atherosclerosis, hyperlipidemia, obesity, and diabetes.", "population_specificity": "Not specified (general discussion of metabolic diseases)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:02.156001+00:00"}
{"study_id": 110776, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the impact of restricting meat, fish, and poultry (and thus altering arachidonic acid intake) on mood state in omnivores.", "results_summary": "Vegetarian participants reduced their arachidonic acid intake and showed significant improvements in mood scores after two weeks, while fish-consuming and omnivorous groups showed no mood changes. The study suggests that reducing arachidonic acid intake may improve short-term mood.", "population_specificity": "39 omnivores randomly assigned to control, fish-consuming, or vegetarian groups.", "effective_dosage": "Not specified (dietary intake assessed via food frequency questionnaire).", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:02.427792+00:00"}
{"study_id": 110778, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid (AA) in the COX pathway and its potential as a therapeutic target for airway inflammation.", "results_summary": "The study found that AA is converted by COX into prostaglandins (PGs), which play a significant role in inflammation and smooth muscle tone, particularly in airway diseases. However, the efficacy of COX inhibitors as therapeutic targets remains unclear, requiring further research.", "population_specificity": "Not specified (general focus on airway inflammation, likely including asthma and COPD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.169873+00:00"}
{"study_id": 110779, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility and precision of using arachidonic acid-triggered multiple electrode aggregometry (MEA) to diagnose high platelet reactivity (HPR) in outpatients with coronary artery disease (CAD).", "results_summary": "The study found that MEA using arachidonic acid was feasible for diagnosing HPR, with 7% of aspirin-treated CAD patients showing HPR. The threshold for HPR diagnosis was set at 55 U for the arachidonic acid test.", "population_specificity": "Healthy individuals (n=50) and outpatients with CAD (n=177) at a distance from acute ischemic episodes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:04.118130+00:00"}
{"study_id": 110781, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers investigated the stability, pharmacokinetic, and pharmacodynamic profile of ARC15105, including its effects on platelet aggregation induced by arachidonic acid and other agonists.", "results_summary": "ARC15105 diminished arachidonic acid-induced platelet aggregation to some extent (P<0.05), though the primary focus was on von Willebrand factor inhibition. The aptamer showed high potency in inhibiting platelet adhesion and aggregation across multiple agonists.", "population_specificity": "Cynomolgus monkeys (in vivo), human serum (in vitro)", "effective_dosage": "1.3 \u03bcmol/L (in vitro), 20 mg/kg (in vivo)", "study_duration": "Up to 72 hours (in vitro), 300 hours post-dose (in vivo)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:05.431786+00:00"}
{"study_id": 110780, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop an integrated metric (PFS) to measure non-COX-1-dependent platelet function (NCDPF) in response to aspirin, using arachidonic acid aggregometry (AAA) to assess COX-1 activity.", "results_summary": "The study found that NCDPF during aspirin therapy is dynamic, with heightened NCDPF declining over time and low/normal NCDPF returning to pre-aspirin levels, despite suppressed COX-1 activity. The PFS strongly correlated with NCDPF measures and showed predictable changes over time.", "population_specificity": "Healthy volunteers (two cohorts: HV1, n=52; HV2, n=96) and diabetics (DM, n=74).", "effective_dosage": "325 mg/day aspirin.", "study_duration": "Several weeks (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:05.972534+00:00"}
{"study_id": 110782, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of arachidonic acid derivatives (anandamide and 2-AG) in the endogenous cannabinoid system and their modulation of anxiety responses.", "results_summary": "The study highlights the complex interactions between arachidonic acid-derived cannabinoids (anandamide and 2-AG) and anxiety-related behaviors, noting variability in outcomes due to genetic, environmental, and compositional factors. It underscores the therapeutic potential of these compounds but also acknowledges challenges in minimizing side effects.", "population_specificity": "Humans and experimental animals (broad review, not specific to a single population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.189451+00:00"}
{"study_id": 110783, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived EETs and sEH inhibitors in chronic inflammatory conditions and their potential as therapeutic agents.", "results_summary": "The study highlights that EETs, derived from arachidonic acid, modulate inflammation and vascular functions, and sEH inhibitors show promise in treating chronic inflammation and associated pain with cardiovascular protective effects. Current anti-inflammatory drugs have limitations, and sEH inhibitors may offer a viable alternative.", "population_specificity": "Not specified (review of existing evidence).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.039424+00:00"}
{"study_id": 110784, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the rate of offset of the anti-platelet effects of aspirin and clopidogrel after stopping treatment and the proportion of untreated donor platelets required to reverse their effects, with a focus on arachidonic acid (AA)-induced platelet aggregation.", "results_summary": "AA-induced platelet aggregation returned to baseline levels within 4 days of stopping aspirin, coinciding with partial recovery of plasma thromboxane B2 concentrations. Mixing with 30% untreated donor platelets restored AA-induced aggregation to control levels in aspirin-treated subjects.", "population_specificity": "Healthy subjects (15 in cohort 1, 36 in cohort 2)", "effective_dosage": "Aspirin 81 mg/day or 325 mg/day; clopidogrel 75 mg/day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:12.341062+00:00"}
{"study_id": 110786, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of 20-HETE, derived from arachidonic acid, in physiological and pathological vascularization, focusing on its effects on vascular smooth muscle cells, endothelial cells, and endothelial progenitor cells.", "results_summary": "The study found that 20-HETE regulates vascular smooth muscle and endothelial cells by influencing proliferation, migration, survival, and tube formation, and stimulates proangiogenic molecule secretion in endothelial progenitor cells through specific signaling pathways. The CYP4A/F-20-HETE system may be a therapeutic target for abnormal angiogenic diseases.", "population_specificity": "Not specified (in vitro or animal models implied, but not explicitly stated).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:12.486437+00:00"}
{"study_id": 110785, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess clopidogrel responsiveness in Iranian patients post-PCI, using arachidonic acid as one of the platelet aggregation measurement agents.", "results_summary": "The study measured platelet aggregation using arachidonic acid but did not report specific outcomes related to its efficacy or effects. Clopidogrel responsiveness varied over time, with maximal nonresponsiveness at 2 hours post-dose.", "population_specificity": "Iranian patients (79 men, 33 women) undergoing elective PCI.", "effective_dosage": "500 and 5000 \u03bcg/mL arachidonic acid (used for platelet aggregation testing).", "study_duration": "Measurements taken at baseline, 2 hours, 24 hours, and 30 days post-PCI.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.030612+00:00"}
{"study_id": 110787, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether reducing the n-6:n-3 LCPUFA ratio (including arachidonic acid intake) during pregnancy and lactation affects infant fat mass during the first year of life.", "results_summary": "The study found no significant differences in infant fat mass, growth, or abdominal fat distribution between the intervention (reduced arachidonic acid intake + n-3 supplementation) and control groups.", "population_specificity": "208 healthy pregnant women and their infants.", "effective_dosage": "1200 mg n-3 LCPUFAs per day (with concomitant reduction in arachidonic acid intake).", "study_duration": "From the 15th week of pregnancy to 4 months postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.225955+00:00"}
{"study_id": 110789, "supplement_id": 885, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ARA supplementation affects clinical parameters related to cardiovascular, inflammatory, and allergic diseases in elderly individuals, as well as its impact on ARA metabolite levels.", "results_summary": "ARA supplementation increased plasma phospholipid ARA content dose-dependently but did not alter clinical blood parameters or ARA metabolite levels, suggesting no induction of cardiovascular, inflammatory, or allergic diseases.", "population_specificity": "Japanese healthy men and women aged 55-70 years.", "effective_dosage": "240 or 720 mg ARA per day.", "study_duration": "4 weeks of supplementation followed by a 4-week washout period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:14.559224+00:00"}
{"study_id": 110788, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate changes in platelet reactivity using arachidonic acid (ASPI test) in CABG patients and assess the effectiveness of antiplatelet therapy.", "results_summary": "The study found that 46.5% of post-CABG patients had residual platelet reactivity (RPR) despite higher ASA doses, with diabetic patients showing higher RPR. Dual antiplatelet therapy (APT) was suggested for optimization.", "population_specificity": "99 patients undergoing elective CABG, including 41 diabetic patients.", "effective_dosage": "100 mg ASA preoperatively, 300 mg ASA postoperatively, and 75 mg clopidogrel for some patients.", "study_duration": "Blood samples were taken preoperatively and on the 1st and 4th postoperative days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:15.537432+00:00"}
{"study_id": 110790, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers examined how lipid-lowering therapy with strong statins affected serum PUFA levels, including arachidonic acid (AA), in patients with coronary artery disease.", "results_summary": "The study found that strong statin treatment significantly decreased the sum of dihomo-\u03b3-linolenic acid (DGLA) and arachidonic acid (AA) levels, as well as the sum of EPA and DHA levels, altering their ratios. The reduction in LDL cholesterol correlated with the decrease in EPA and DHA levels.", "population_specificity": "46 patients with coronary artery disease and LDL cholesterol >100 mg/dl.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Strong statins (atorvastatin, rosuvastatin, pitavastatin) reduced AA levels.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:15.891491+00:00"}
{"study_id": 110791, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of arachidonic acid and other PUFAs as tumor-targeting drug carriers to enhance the therapeutic efficacy of anticancer drugs.", "results_summary": "The study found that PUFAs, including arachidonic acid, can be effectively incorporated into tumor cell lipid bilayers, making them promising carriers for anticancer drugs. Several PUFA-drug conjugates demonstrated potent antitumor activities, suggesting their potential in drug development.", "population_specificity": "Tumor cells (preclinical focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:16.914622+00:00"}
{"study_id": 110794, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid as an inflammatory mediator in Kounis syndrome, a condition involving mast cell activation and acute coronary syndromes.", "results_summary": "The abstract identifies arachidonic acid as one of the inflammatory mediators released during mast cell activation in Kounis syndrome, contributing to coronary events, but does not provide specific efficacy or safety data on arachidonic acid itself.", "population_specificity": "Patients with Kounis syndrome (acute coronary syndromes associated with mast cell activation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:21.346488+00:00"}
{"study_id": 110793, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the reno-protective mechanisms of epoxyeicosatrienoic acids (EETs), derived from arachidonic acid, in cardiovascular disease (CVD) and their potential to prevent end-stage renal disease (ESRD).", "results_summary": "The study found that EETs, derived from arachidonic acid, exhibit vasodilatory, anti-inflammatory, antihypertensive, and antiplatelet aggregation properties, and their levels are linked to CVD progression. Inhibiting their degradation or using stable analogs showed promise in reducing blood pressure and organ damage in experimental models.", "population_specificity": "Hypertensive animal models and experimental models of CVD and metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:21.888465+00:00"}
{"study_id": 110795, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of COX-derived prostaglandins, including those influenced by arachidonic acid, in skin inflammation and cancer development.", "results_summary": "The study found that arachidonic acid, as a chemical noxious stimulus, contributes to skin inflammation and cancer development through COX-2 overexpression and prostaglandin signaling, with COX-2 playing a critical role in tumor promotion and progression.", "population_specificity": "Mice and human studies (epidemiological and clinical) related to non-melanoma skin cancer (SCC and BCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.587786+00:00"}
{"study_id": 110792, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived eicosanoids in colorectal cancer development and progression, and explore potential therapeutic strategies targeting these pathways.", "results_summary": "The study found that arachidonic acid metabolism influences colorectal cancer progression through various eicosanoid pathways, with inhibition of these pathways generally suppressing tumor growth. Dietary factors, such as omega-3 fatty acids, also modulate eicosanoid effects in colorectal cancer prevention or treatment.", "population_specificity": "Focus on colorectal cancer development and progression, but no specific human or animal population is detailed in the abstract.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:23.050129+00:00"}
{"study_id": 110797, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived prostaglandins in tumor development and the anti-tumorigenic effects of NSAIDs, including their impact on gene expression.", "results_summary": "The study found that prostaglandins derived from arachidonic acid contribute to tumor development, while NSAIDs inhibit tumor growth and alter gene expression, particularly through the induction of NAG-1, which suppresses tumor development in mouse models.", "population_specificity": "Not specified (review of existing research, including mouse models).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:23.645919+00:00"}
{"study_id": 110798, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of arachidonic acid metabolites, particularly prostaglandins (PGs) and their EP receptors, in the development of non-melanoma skin cancer (NMSC) induced by UV light or chemical carcinogens.", "results_summary": "The study found that COX-2-derived PGE(2) plays a significant role in NMSC development, with EP1, EP2, and EP4 receptors contributing to tumor promotion through different signaling pathways. COX-2 deficiency protected against NMSC, while overexpression promoted tumorigenesis.", "population_specificity": "Mouse skin models exposed to UV light or chemical carcinogens.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.019176+00:00"}
{"study_id": 110799, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the biological actions of hepoxilins (HX), metabolites of arachidonic acid, and their synthetic antagonists (PBTs) in inflammation, thrombosis, and diabetes-related complications.", "results_summary": "The study found that HX metabolites act as pro-inflammatory chemoattractants and are involved in bacterial infections, while PBTs (HX antagonists) showed efficacy in animal models of cancer, inflammation, thrombosis, and hypoglycemia with minimal side effects.", "population_specificity": "Animal models (specific species not mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.085217+00:00"}
{"study_id": 110796, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to characterize the novel compound EP6 as a 5-LO inhibitor and evaluate its potential to suppress leukotriene formation, addressing inflammatory and allergic diseases.", "results_summary": "EP6 effectively suppressed 5-LO activity in both intact cells and cell-free assays, with IC50 values of 0.16\u03bcM and 0.05\u03bcM, respectively. It demonstrated consistent efficacy regardless of redox tone or AA concentration and showed potential for targeting inflammatory diseases and certain cancers.", "population_specificity": "In vitro studies using polymorphonuclear leukocytes and tumor cells.", "effective_dosage": "IC50 values of 0.16\u03bcM (intact cells) and 0.05\u03bcM (purified 5-LO).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.158630+00:00"}
{"study_id": 110800, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of arachidonic acid in prostaglandin E(2) (PGE(2)) synthesis and its impact on cancer progression, particularly in regulating mRNA stability and protein translation.", "results_summary": "The study found that arachidonic acid is a key precursor in PGE(2) synthesis, which promotes tumor growth by activating signaling pathways for cell proliferation, migration, apoptosis, and angiogenesis. RNA sequence elements in the 3'UTR of genes involved in the PGE(2) pathway regulate its synthesis, suggesting potential therapeutic targets.", "population_specificity": "Not specified (focus on molecular mechanisms in cancer).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:30.428987+00:00"}
{"study_id": 110803, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether fish oil supplementation modulates arachidonic acid metabolism in men with low-risk prostate cancer.", "results_summary": "The study found that fish oil supplementation modulated arachidonic acid metabolism (p=0.01) compared to placebo, but no significant individual genes were associated with this effect.", "population_specificity": "84 men with low-risk prostate cancer, stratified by dietary fish and tomato consumption.", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:30.623271+00:00"}
{"study_id": 110801, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the roles of cyclooxygenase- and lipoxygenase-derived eicosanoids, including arachidonic acid metabolites, in cancer progression and their potential as targets for cancer prevention and treatment.", "results_summary": "The study found that arachidonic acid-derived eicosanoids (prostanoids and HETEs) are produced by tumor cells and can regulate cell growth, survival, migration, and invasion, suggesting their involvement in cancer progression. The review discusses the potential of targeting these enzymes for cancer therapy but also highlights challenges in this approach.", "population_specificity": "Tumor cells in vitro and in vivo (no specific human population mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.338169+00:00"}
{"study_id": 110805, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare platelet aggregation responses to arachidonic acid in arterial versus venous blood samples in patients with coronary artery disease (CAD).", "results_summary": "The study found that arterial and venous blood samples yielded similar platelet aggregation data when assessing responses to arachidonic acid, with identical detection rates of 'low responders' to antiplatelet therapy.", "population_specificity": "28 patients with coronary artery disease (CAD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:32.306466+00:00"}
{"study_id": 110808, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review recent findings on the role of 20-HETE, a metabolite of arachidonic acid, in cardiovascular function and its implications in diseases like hypertension.", "results_summary": "The study highlights that 20-HETE is a central mediator of cardiovascular function, influencing oxidative stress, endothelial dysfunction, and hypertension, with potential for therapeutic intervention.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:32.371472+00:00"}
{"study_id": 110802, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether colchicine (not Arachidonic Acid) affected platelet function, including aggregation induced by Arachidonic Acid, in patients with acute coronary syndrome or acute ischemic stroke.", "results_summary": "The study found no significant difference in platelet function, including aggregation induced by Arachidonic Acid, between colchicine and placebo groups. Arachidonic Acid was used only as an agonist in platelet function tests, not as a supplement or intervention.", "population_specificity": "80 patients with acute coronary syndrome or acute ischemic stroke.", "effective_dosage": "Arachidonic Acid was used at 0.5 mmol for platelet aggregation tests.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:33.077201+00:00"}
{"study_id": 110804, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of arachidonic acid (AA)-derived lipids in modulating Chagas disease progression and their potential as therapeutic targets.", "results_summary": "The study found that AA-derived lipids (e.g., leukotrienes, prostaglandins) significantly influence acute and chronic Chagas disease progression, with COX inhibitors showing mixed effects\u2014beneficial in chronic infection but harmful in acute infection. Parasite-derived TXA(2) may act as a quorum sensor, and eicosanoids likely aid the transition to chronic disease while later contributing to cardiovascular damage.", "population_specificity": "Mice (COX-1 null and wild-type) and inferred human implications for Chagas disease patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "COX inhibitors (e.g., NSAIDs) may have adverse effects during acute T. cruzi infection but benefits in chronic infection.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:33.779607+00:00"}
{"study_id": 110806, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived eicosanoids in tumor-associated inflammation and their potential as therapeutic targets for inhibiting tumor growth.", "results_summary": "The study found that arachidonic acid metabolites (eicosanoids) play a central role in inflammation and cancer, with potential anti-tumor effects through pathways like COX and LOX inhibition, receptor antagonism, and enzyme overexpression. Dietary nutrients, such as omega-3 fatty acids, can influence eicosanoid biosynthesis, suggesting a link between diet and cancer prevention.", "population_specificity": "Not specified (general review of preclinical and clinical evidence).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:34.874099+00:00"}
{"study_id": 110810, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review recent advances in eicosanoid biology, particularly the role of the CYP/sEH axis in vascular biology and disease, focusing on the effects of arachidonic acid metabolites.", "results_summary": "The study found that CYP-derived metabolites of arachidonic acid, such as fatty acid epoxides and diols, play significant roles in vascular smooth muscle relaxation and are linked to hypertension and inflammation. Targeting sEH to manipulate these metabolites shows promise in treating hypertension and inflammation/atherosclerosis.", "population_specificity": "Animal models (mice) and potential implications for human hypertension and inflammation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.633608+00:00"}
{"study_id": 110809, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to assess the long-term effects of prenatal supplementation with LC-PUFAs (including arachidonic acid) and folate on cognitive development in offspring at 6.5 years of age.", "results_summary": "The study found no significant differences in cognitive function between intervention groups, but maternal DHA status was associated with better cognitive outcomes in children. Arachidonic acid was included in infant formula for certain groups but its specific effects were not highlighted.", "population_specificity": "Healthy pregnant women in three European centers and their offspring.", "effective_dosage": "Infants received formula containing 0.4% arachidonic acid if born to mothers receiving fish oil supplements.", "study_duration": "Supplementation from the 20th week of pregnancy until delivery; infant formula until 6 months of age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.897938+00:00"}
{"study_id": 110811, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the laboratory response to aspirin (using arachidonic acid-induced tests) in ACS patients before and after PCI and clopidogrel treatment, and its correlation with clinical outcomes.", "results_summary": "The study found that response to aspirin improved significantly after PCI and clopidogrel treatment, with reduced platelet reactivity (measured via arachidonic acid-induced LTA and IMPACT-R tests). Improved response correlated with better clinical outcomes during follow-up.", "population_specificity": "63 consecutive patients with acute coronary syndrome (ACS).", "effective_dosage": "Not specified", "study_duration": "Follow-up for clinical events up to 15 months post-PCI.", "interactions": "Clopidogrel treatment was noted to correlate with improved aspirin response.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:40.530284+00:00"}
{"study_id": 110812, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore how fatty acids, particularly arachidonic acid, influence inflammation and inflammatory cell function, and the potential therapeutic effects of marine n-3 fatty acids.", "results_summary": "Arachidonic acid is involved in inflammation through eicosanoid production, while EPA and DHA produce anti-inflammatory resolvins. Marine n-3 fatty acids show therapeutic efficacy in rheumatoid arthritis but benefits in other inflammatory conditions are less clear.", "population_specificity": "Human inflammatory cells and conditions like rheumatoid arthritis, atherosclerosis, and cardiovascular diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:42.789478+00:00"}
{"study_id": 110814, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if twice-daily dosing of aspirin (which affects arachidonic acid pathways) would improve platelet inhibition in high-risk type 2 diabetes patients compared to once-daily dosing.", "results_summary": "Twice-daily aspirin (75 mg BID) reduced arachidonic acid-induced platelet aggregation more effectively than once-daily dosing (75 mg OD or 320 mg OD), though urinary thromboxane reduction was only significant with high-dose (320 mg OD) aspirin. Platelet turnover markers correlated with arachidonic acid-induced aggregation but did not reliably predict response to BID dosing.", "population_specificity": "25 patients with type 2 diabetes and micro- or macrovascular complications.", "effective_dosage": "75 mg once daily (OD), 75 mg twice daily (BID), and 320 mg once daily (OD).", "study_duration": "\u22652 weeks per treatment period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.559815+00:00"}
{"study_id": 110816, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of aspirin on platelet-related inflammatory biomarkers, including platelet aggregation under arachidonic acid (AA) stimulation, in acute stroke patients and healthy volunteers.", "results_summary": "The study found that aspirin effectively inhibited COX-1-dependent platelet aggregation under AA stimulation in both stroke patients and healthy individuals, but it did not influence platelet \u03b1-granule-derived inflammatory mediators or monocyte-platelet aggregation in stroke subjects.", "population_specificity": "63 acute stroke patients and 40 healthy volunteers.", "effective_dosage": "150 mg daily.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.864604+00:00"}
{"study_id": 110815, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of clopidogrel withdrawal on arachidonic acid-induced platelet aggregation and biomarkers of vascular inflammation in patients with drug-eluting stents.", "results_summary": "The study found an unexpected increase in arachidonic acid-induced platelet aggregation after clopidogrel withdrawal, alongside declines in IL-6 and hsCRP, suggesting a potential mechanism for adverse events post-cessation.", "population_specificity": "33 patients receiving aspirin and discontinuing clopidogrel 1 year after drug-eluting stent implantation.", "effective_dosage": "Not specified", "study_duration": "Measurements taken up to 4 weeks post-clopidogrel cessation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:44.080545+00:00"}
{"study_id": 110818, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review analytical methods for quantifying oleic acid metabolites (cis-EpOA, 9-NO(2)-OA, and 10-NO(2)-OA) in biological samples and explore their potential biological significance.", "results_summary": "The study detected cis-EpOA, 9-NO(2)-OA, and 10-NO(2)-OA in human plasma using GC-MS/MS and LC-MS/MS techniques. It suggested that cis-EpOA synthesis is liver-dependent and proposed nitro-oleic acids as potential biomarkers for fatty acid nitration.", "population_specificity": "Healthy and ill human subjects (not further specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.927777+00:00"}
{"study_id": 110817, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate changes in fatty acid and lipid profiles, including arachidonic acid, in children with PN-cholestasis after switching from a soybean oil-based lipid emulsion (SOLE) to a fish-oil-based lipid emulsion (FOLE).", "results_summary": "The study found that switching to FOLE significantly decreased serum omega-6 fatty acids, including arachidonic acid, while improving lipid profiles and cholestasis markers. The reduction in arachidonic acid was associated with improved triglyceride and VLDL concentrations.", "population_specificity": "Pediatric patients (median age 91 days) with PN-cholestasis receiving parenteral nutrition.", "effective_dosage": "FOLE at 1 g \u00b7 kg(-1) \u00b7 d(-1).", "study_duration": "Median of 18.3 weeks (interquartile range: 9.4-41.4 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:50.134377+00:00"}
{"study_id": 110820, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize recent findings on the role of arachidonic acid metabolites in diabetes and its complications, and to identify potential therapeutic targets.", "results_summary": "The study found that arachidonic acid metabolites, particularly those from the COX and LOX pathways, contribute to pancreatic \u03b2-cell dysfunction and destruction in diabetes, while CYP eicosanoids like EETs may improve \u03b2-cell function when stabilized.", "population_specificity": "Not specified (review of existing studies, likely involving animal models and in vitro research).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:51.022370+00:00"}
{"study_id": 110819, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of enzyme replacement therapy (ERT) on platelet function, including response to arachidonic acid (AA), in treatment-na\u00efve patients with Gaucher's disease.", "results_summary": "Platelet aggregation in response to arachidonic acid significantly increased after 6 months of ERT (from 0.7 to 0.8, p < 0.05), indicating improved platelet function. Splenic volume inversely correlated with reduced AA response, suggesting a relationship between spleen size and AA-mediated platelet dysfunction.", "population_specificity": "31 Serbian treatment-na\u00efve type 1 Gaucher's disease patients (17 male, 14 female; median age 49 years; 9 splenectomized).", "effective_dosage": "Not specified for AA (used as an aggregometry agonist at undisclosed concentration).", "study_duration": "24 months (assessments at 6, 12, and 24 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:51.466954+00:00"}
{"study_id": 110822, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid and other lipid mediators in Alzheimer's disease pathology and potential neuroprotective mechanisms.", "results_summary": "The study suggests that arachidonic acid, released from glycerophospholipids, is involved in neuronal pathways linked to Alzheimer's disease, with its oxidation products potentially influencing disease progression. Dietary lipid modulation may slow neurodegenerative processes.", "population_specificity": "Not specified (focus on Alzheimer's disease neurobiology).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:52.403648+00:00"}
{"study_id": 110813, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how marine n-3 fatty acids and \u03b3-linolenic acid, alone or combined, affect the AA/EPA ratio and inflammatory markers in arthritis patients.", "results_summary": "The study found that n-3 LC-PUFA (group 1) significantly reduced the AA/EPA ratio in plasma lipids and erythrocyte membranes, while \u03b3-linolenic acid (group 2) increased \u03b3-linolenic acid and dihomo-\u03b3-linolenic acid concentrations. The combination (group 3) showed intermediate effects.", "population_specificity": "Patients with rheumatoid arthritis (54) or psoriatic arthritis (6).", "effective_dosage": "Group 1: 3.0 g n-3 LC-PUFA/day; Group 2: 3.2 g \u03b3-linolenic acid/day; Group 3: 1.6 g n-3 LC-PUFA + 1.8 g \u03b3-linolenic acid/day; Group 4: 3.0 g olive oil (placebo).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:52.530940+00:00"}
{"study_id": 110821, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the prevalence of aspirin resistance (AR) and identify risk factors, including genetic variants like TBXA2R-924T, affecting aspirin responsiveness in patients with unstable coronary artery disease using arachidonic acid (ARA)-induced platelet aggregation tests.", "results_summary": "The study found that 8.8% of patients exhibited AR after aspirin treatment, with higher urinary 11-DH-TXB2 levels in the AR group. TBXA2R-924TT homozygotes had a significantly higher AR rate, and diabetes was an independent risk factor for AR.", "population_specificity": "262 patients with unstable coronary artery disease who had not taken aspirin before admission.", "effective_dosage": "Not specified", "study_duration": "Follow-up at days 1, 4, and 10 post-aspirin administration, with a 6-month follow-up for AR patients.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:53.410249+00:00"}
{"study_id": 110823, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether prescription omega-3-acid ethyl esters (PO-3A) could inhibit platelet activity in patients with stable coronary artery disease (CAD) beyond the effects of aspirin and statins, including its impact on arachidonic acid-induced platelet aggregation.", "results_summary": "The study found that PO-3A did not affect arachidonic acid-induced platelet aggregation, along with several other platelet activity markers, suggesting no significant impact on this pathway. However, PO-3A modestly reduced other platelet activity biomarkers like ADP-induced aggregation and P-selectin expression.", "population_specificity": "Thirty patients with documented CAD and triglycerides over 250 mg/dl, treated with aspirin and statins.", "effective_dosage": "Omacor\u2122 1 g/day or 2 g/day (DHA/EPA ratio 1.25:1.0).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:54.186315+00:00"}
{"study_id": 110824, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the developmental differences in biological significance and effects of arachidonic acid (PUFA-OMEGA-6) compared to docosahexaenoic acid (PUFA-OMEGA-3), focusing on their immunological and anti-inflammatory roles.", "results_summary": "The study highlighted the contrasting effects of arachidonic acid and its metabolites, which have significant impacts compared to the anti-inflammatory actions of PUFA-OMEGA-3. It proposed an evolutionary hypothesis for their mutual relationship, with immunological implications and potential recuperative effects.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.236351+00:00"}
{"study_id": 110827, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine the effect of arachidonic acid (AA) on the progression of prostate cancer cells to an androgen-independent state.", "results_summary": "The study found that arachidonic acid promoted the growth of LNCaP prostate cancer cells under hormone-depleted conditions, contrasting with the inhibitory effects of omega-3 fatty acids. This effect was associated with changes in androgen receptor expression and Akt/mTOR signaling.", "population_specificity": "In vitro model using LNCaP prostate cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:59.345952+00:00"}
{"study_id": 110825, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the levels of circulating CYP450 metabolites, including arachidonic acid metabolites, in acute ischaemic stroke patients compared to healthy controls and assess their association with stroke outcomes.", "results_summary": "Acute ischaemic stroke patients had significantly elevated plasma levels of CYP450 arachidonic acid metabolites (20-HETE, EETs, DiHETEs) and oxidative stress markers compared to controls. These levels were attenuated 30 days post-stroke, and baseline 20-HETE levels correlated with lesion size and functional indices.", "population_specificity": "44 acute ischaemic stroke patients (<96 hours post-stroke) and 44 age- and gender-matched healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified (retrospective analysis with follow-up at 30 days post-stroke)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:59.648861+00:00"}
{"study_id": 110826, "supplement_id": 885, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of different HIV protease inhibitors (TPV/r, DRV/r, RTV) on arachidonic acid (AA)-induced platelet aggregation in healthy volunteers.", "results_summary": "TPV/r inhibited AA-induced platelet aggregation in some subjects, with effects reversed 24 hours post-dose. Variability in antiplatelet effects was observed across treatments, ranging from no effect to complete inhibition. No PI treatment increased bleeding time or affected coagulation factors.", "population_specificity": "Healthy volunteers with normal platelet aggregation and AA-induced platelet aggregation inhibition after aspirin.", "effective_dosage": "325 mg aspirin (single dose); PI therapies administered twice daily (specific dosages not detailed).", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:00.089004+00:00"}
{"study_id": 110829, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the cardiovascular protective effects of inhibiting soluble epoxide hydrolase (sEH), which degrades epoxyeicosatrienoic acids (EETs) derived from arachidonic acid.", "results_summary": "The study found that sEH inhibition (sEHIs) had cardiovascular protective effects, including vasodilation, anti-inflammation, and protection against end-organ damage, suggesting potential therapeutic benefits for cardiovascular diseases. EETs, derived from arachidonic acid, were highlighted as key mediators in these processes.", "population_specificity": "Not specified (general cardiovascular disease context).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:00.710159+00:00"}
{"study_id": 110831, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review published literature to elucidate the mechanism(s) of action of a natural product (peroxide oil) containing arachidonic acid-related components for analgesic effects.", "results_summary": "The study found that peroxide oil contains ingredients linked to analgesic mechanisms, including inhibition of arachidonic acid metabolism and activation of non-opioid, receptor-mediated pathways, suggesting potential additive or synergistic effects. However, the exact mechanism remains unclear.", "population_specificity": "Not specified (literature review of preclinical and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:02.013902+00:00"}
{"study_id": 110830, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid (AA) in inflammation and immune response, comparing its effects to those of n-3 fatty acids (EPA and DHA) in critically ill patients.", "results_summary": "The study found that AA-derived lipid mediators are pro-inflammatory, while n-3 fatty acids (EPA and DHA) produce less inflammatory mediators and promote resolution of inflammation. Modulating the n-6/n-3 ratio may improve outcomes in critically ill patients, such as reducing length of stay and infectious complications.", "population_specificity": "Critically ill patients and animal models (acute lung injury and sepsis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:02.376893+00:00"}
{"study_id": 110828, "supplement_id": 885, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers sought to determine how escalating doses of omega-3 PUFA supplements affect platelet function, particularly in relation to arachidonic acid-mediated platelet activation.", "results_summary": "The study found that omega-3 PUFA increased the negative resting platelet charge and attenuated platelet activation in response to arachidonic acid, even in patients taking aspirin or aspirin plus clopidogrel. No bleeding events were observed.", "population_specificity": "30 volunteers divided into three groups: no antiplatelet agents, daily aspirin only, and daily aspirin plus clopidogrel.", "effective_dosage": "Escalating doses from 1 to 8 g daily.", "study_duration": "24 weeks.", "interactions": "Attenuated response to arachidonic acid-mediated platelet activation in patients taking aspirin or aspirin plus clopidogrel.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:02.400942+00:00"}
{"study_id": 110833, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between COX-2-mediated metabolism of arachidonic acid and its downstream effects on IDO1 activity in chronic inflammation and cancer.", "results_summary": "The study suggests that COX-2 metabolizes arachidonic acid into prostanoids like PGE2, which has pro-inflammatory and immune regulatory effects, and that COX-2 inhibition may downregulate IDO1 expression and kynurenine levels in cancer models.", "population_specificity": "Preclinical animal models of cancer and chronic inflammation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.473184+00:00"}
{"study_id": 110835, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid (an omega-6 fatty acid) in supporting normal visual development in infants, particularly preterm neonates.", "results_summary": "The study suggests that infant formulas containing arachidonic acid, along with docosahexaenoic acid (DHA), may protect non-breastfed infants against visual development abnormalities by supporting neurological and ocular maturation.", "population_specificity": "Infants, particularly preterm neonates.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.647283+00:00"}
{"study_id": 110832, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the fatty acid profile of fresh lamb meat with processed baby foods to assess the retention of arachidonic acid and other essential fatty acids during processing.", "results_summary": "The study found that fresh lamb meat contained over 6-fold higher arachidonic acid compared to homogenized and lyophilized baby foods, suggesting significant loss during processing. The results highlight the potential to enhance commercial baby food formulations by preserving these essential fatty acids.", "population_specificity": "Children with atopic dermatitis and multiple food hypersensitivities, as well as infants in regions where lamb meat is commonly used as a weaning food.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.961972+00:00"}
{"study_id": 110834, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the mechanisms of prostaglandin generation from arachidonic acid and their roles in modulating inflammation and related pathologies.", "results_summary": "The study found that prostaglandins derived from arachidonic acid play dual roles in both promoting and resolving inflammation, with clinical relevance for conditions like atherosclerosis and vascular injury. Nonsteroidal anti-inflammatory drugs (NSAIDs) block prostaglandin biosynthesis, highlighting their therapeutic potential.", "population_specificity": "Not specified (general review of biological mechanisms)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "Nonsteroidal anti-inflammatory drugs (NSAIDs), including cyclooxygenase-2 inhibitors", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:08.755026+00:00"}
{"study_id": 110836, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the incidence and clinical impact of dual high on-treatment platelet reactivity (DAPR) to both aspirin and clopidogrel, measured using arachidonic acid-induced light transmittance aggregometry (LTA) and the VerifyNow system.", "results_summary": "The study found that DAPR, assessed via arachidonic acid-induced LTA and VerifyNow, was present in 14.7% to 26.9% of patients and was highly associated with adverse clinical outcomes, including higher rates of atherothrombotic events compared to patients without high on-treatment platelet reactivity.", "population_specificity": "Patients on dual antiplatelet therapy undergoing elective coronary stent implantation.", "effective_dosage": "Not specified", "study_duration": "1-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:09.491682+00:00"}
{"study_id": 110837, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the roles of CYP epoxygenases and arachidonic acid-derived metabolites (EETs) in cardiovascular functions and malignancy under physiological and pathological conditions.", "results_summary": "The study found that CYP epoxygenases and EETs have cardiovascular protective effects, including vasodilation, anti-hypertension, and anti-inflammation, but also promote tumor progression and metastasis. Soluble epoxide hydrolase (sEH) inhibitors showed anti-hypertensive and anti-inflammatory effects, while CYP2J2 inhibitors exhibited anti-tumor activity.", "population_specificity": "Not specified (involved transgenic animals and human tumor analyses).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:10.722700+00:00"}
{"study_id": 110838, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the roles of CYP enzymes, particularly in metabolizing arachidonic acid, and their impact on ischemia-reperfusion injury in the heart.", "results_summary": "The study found that CYP enzymes metabolize arachidonic acid into cardioprotective eicosanoids (EETs) but also generate reactive oxygen species (ROS), with CYP2J2 producing beneficial EETs and CYP2C producing both EETs and harmful ROS. These mechanisms influence cardiomyocyte survival during ischemia and reperfusion injury.", "population_specificity": "Not specified (focus on cardiac CYP enzymes and their metabolic roles).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:10.848424+00:00"}
{"study_id": 110839, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived endocannabinoids in systemic energy metabolism and how dietary \u03c9-3 and \u03c9-6 polyunsaturated fatty acids influence ECS activation.", "results_summary": "The study found that a diet high in \u03c9-6 polyunsaturated fatty acids (including arachidonic acid) increases ECS activation, leading to fat accumulation and reduced insulin sensitivity, while \u03c9-3 polyunsaturated fatty acids decrease ECS activation, improving metabolic outcomes.", "population_specificity": "Animal and human subjects, particularly obese patients with metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:11.118591+00:00"}
{"study_id": 110843, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of arachidonic acid derivatives in the inflammatory phases of atopic asthma.", "results_summary": "The study identified arachidonic acid derivatives as contributors to the second phase of airway inflammation in asthma, alongside cytokines and other molecules, but did not quantify their specific effects.", "population_specificity": "Asthma patients with atopic (allergic) asthma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:15.586010+00:00"}
{"study_id": 110841, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolism via Cox-2 in cancer progression and the potential of Cox-2 inhibitors as anti-cancer agents.", "results_summary": "The study found that Cox-2, which metabolizes arachidonic acid, is overexpressed in cancer and stroma cells, promoting tumor progression, angiogenesis, and resistance to apoptosis. Cox-2 inhibitors like NSAIDs and celecoxib showed potent anti-cancer activity, suggesting a therapeutic target.", "population_specificity": "Cancer cells and stroma cells (in vitro or animal models implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:16.082447+00:00"}
{"study_id": 110842, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Arachidonic Acid (ARA) and Docosahexaenoic Acid (DHA) on age-related declines in brain and cardiovascular function.", "results_summary": "ARA supplementation improved cognitive function in elderly men and patients with mild cognitive impairment (MCI) or organic brain lesions, as well as enhanced coronary flow velocity reserve in elderly individuals, suggesting benefits for brain and cardiovascular health.", "population_specificity": "Aged rats, healthy elderly men, patients with mild cognitive impairment (MCI), and patients with organic brain lesions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:16.245840+00:00"}
{"study_id": 110840, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of higher-dose DHA (with constant arachidonic acid content) on the growth of pre-term infants compared to standard feeding practices.", "results_summary": "The study found no adverse effect of higher DHA (with constant arachidonic acid) on growth, with infants fed higher DHA showing a slight increase in length at 18 months. Higher DHA improved length in infants born weighing \u2265 1250 g at 4 months and both weight and length at 12 and 18 months.", "population_specificity": "Pre-term infants born < 33 weeks gestation (n=657).", "effective_dosage": "Arachidonic acid content was constant at approximately 0.4% of total fatty acids.", "study_duration": "From day 2 to 5 of life until the infant's expected date of delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:17.218936+00:00"}
{"study_id": 110844, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers compared the effects of elemental and polymeric formulas on remission induction in pediatric Crohn's disease, including changes in plasma fatty acids like arachidonic acid.", "results_summary": "The study found a reciprocal decrease in arachidonic acid (AA) levels with the polymeric formula, while the elemental formula also reduced AA and docosahexaenoic acid levels. Changes in plasma polyunsaturated fatty acids were subtle but may be relevant.", "population_specificity": "Newly diagnosed pediatric Crohn's disease patients (ages ~11.7-12.6 years).", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:18.085144+00:00"}
{"study_id": 110847, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolism in aspirin-exacerbated respiratory disease (AERD) and the impact of aspirin desensitization on chronic sinusitis with nasal polyposis (CRSwNP).", "results_summary": "The study found that modulation of arachidonic acid metabolism and inhibition of inflammatory pathways involving cytokines IL-4 and IL-13 improved clinical outcomes in CRSwNP, reducing polyp recurrence, hospitalizations, and corticosteroid need.", "population_specificity": "Aspirin-intolerant patients with chronic sinusitis and nasal polyposis (CRSwNP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.199653+00:00"}
{"study_id": 110845, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether increasing the frequency of aspirin administration (including arachidonic acid-induced platelet aggregation assessment) could improve platelet inhibition in type 2 diabetes mellitus (T2DM) patients with stable coronary artery disease.", "results_summary": "The study found that a twice-daily low-dose aspirin regimen resulted in greater platelet inhibition than once-daily administration, as measured by aspirin-sensitive assays (collagen-induced aggregation and VerifyNow-Aspirin). Arachidonic acid-induced aggregation confirmed all patients were aspirin-sensitive and compliant, regardless of dose.", "population_specificity": "T2DM patients with stable coronary artery disease (n=20).", "effective_dosage": "81 mg/od, 81 mg/bid, 162 mg/od, 162 mg/bid, and 325 mg/od.", "study_duration": "Weekly modifications of aspirin regimen (total duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:20.435698+00:00"}
{"study_id": 110846, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the fatty acid composition, including arachidonic acid, between SLE patients and healthy controls, and assess its association with inflammation and cardiovascular disease.", "results_summary": "The study found that SLE patients had a higher ratio of arachidonic acid (inflammatory) to EPA (anti-inflammatory) in RBCs compared to healthy controls, suggesting a pro-inflammatory state. No differences were observed in plasma FA composition between SLE and healthy groups.", "population_specificity": "33 female SLE patients (11 with CVD history, 22 without) and 20 age-matched healthy female controls.", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "Prednisone use altered FA composition in SLE patients.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:20.856478+00:00"}
{"study_id": 110848, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether atorvastatin improves platelet sensitivity to aspirin (ASA) in hypercholesterolemic patients, particularly in the context of arachidonic acid- or collagen-induced platelet aggregation.", "results_summary": "The study found that atorvastatin increased platelet sensitivity to ASA in hypercholesterolemic patients, with significant inhibition of arachidonic acid- and collagen-induced platelet aggregation. This effect was associated with reduced platelet cholesterol content and increased ASA-induced acetylation of platelet proteins.", "population_specificity": "Hypercholesterolemic patients (n=27)", "effective_dosage": "50 \u03bcM ASA (in vitro), 10mg/day atorvastatin", "study_duration": "1, 3, or 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.471891+00:00"}
{"study_id": 110851, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine how early undernutrition involving a deficiency in long-chain polyunsaturated fatty acids, including arachidonic acid, affects brain development and cognitive function.", "results_summary": "The study highlights that arachidonic acid is crucial for normal brain development, and deficiencies in it during early life can lead to adverse effects on brain anatomy, physiology, and cognitive abilities, particularly spatial learning.", "population_specificity": "Mothers and children in developing countries affected by undernutrition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.681231+00:00"}
{"study_id": 110849, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether low-dose naproxen sodium interferes with aspirin's antiplatelet effect, particularly in relation to arachidonic acid-induced platelet aggregation.", "results_summary": "The study found that naproxen given before aspirin slightly reduced the inhibition of serum thromboxane B(2) compared to aspirin alone, but all treatments maximally inhibited arachidonic acid-induced platelet aggregation. Collagen-induced platelet aggregation remained inhibited only with aspirin alone.", "population_specificity": "9 healthy volunteers", "effective_dosage": "220 mg naproxen twice daily, aspirin dosage not specified", "study_duration": "6 days per treatment with 14-day washout periods", "interactions": "Sequential administration of naproxen and aspirin interfered with aspirin's irreversible inhibition of platelet cyclooxygenase 1.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.952791+00:00"}
{"study_id": 110850, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of arachidonic acid-derived eicosanoids (20-HETE and EETs) in regulating cerebral blood flow and their potential as therapeutic targets for cerebral vascular diseases.", "results_summary": "The study found that 20-HETE and EETs significantly contribute to cerebral blood flow regulation and neurovascular coupling. Inhibition of 20-HETE or increasing EET levels by inhibiting sEH enzyme improved outcomes following cerebral ischemia by protecting neurons and enhancing vascular function.", "population_specificity": "Not specified (general cerebral vascular function and stroke models implied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:25.259214+00:00"}
{"study_id": 110852, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers proposed exploring the potential of anti-inflammatory and pro-resolving mediators derived from arachidonic acid as a treatment for allergies, particularly in the context of maternal nutrition and allergy prevention in newborns.", "results_summary": "The abstract suggests that lipid mediators like lipoxins, resolvins, and protectins, derived from arachidonic acid, may offer a novel approach to allergy prevention and treatment, aligning with maternal dietary strategies involving omega-3 fatty acids. However, no specific clinical outcomes or statistical results are provided.", "population_specificity": "Pregnant women and newborns (focus on allergy prevention).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.483213+00:00"}
{"study_id": 110854, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare two platelet function tests (VerifyNow Assay and MEA) for predicting early clinical outcomes after percutaneous coronary intervention, focusing on arachidonic acid-induced platelet aggregation.", "results_summary": "The study found weak correlations between the two tests for arachidonic acid-induced platelet reactivity. VerifyNow P2Y12 Assay predicted periprocedural MI and 30-day MACE, but VerifyNow Aspirin Assay and MEA tests did not. Hyporesponsiveness to clopidogrel measured by VerifyNow Assay was linked to a higher risk of MACE.", "population_specificity": "222 patients undergoing percutaneous coronary intervention.", "effective_dosage": "Not specified", "study_duration": "30-day follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.050135+00:00"}
{"study_id": 110853, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether maternal supplementation with arachidonic acid (AA) alone or in combination with docosahexaenoic acid (DHA) during pregnancy and lactation influences neurodevelopment in toddlers.", "results_summary": "The study found that maternal supplementation with DHA+AA or DHA alone did not significantly influence neurodevelopmental outcomes at 18 months. However, perinatal DHA and AA status showed some associations with minor neurological dysfunction and developmental indices.", "population_specificity": "Pregnant and lactating women and their infants, assessed at 18 months postpartum.", "effective_dosage": "220 mg/day of AA (in combination with 220 mg/day DHA).", "study_duration": "During pregnancy and lactation (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.354409+00:00"}
{"study_id": 110856, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 88, "quality_score": 92, "study_goal": "The researchers aimed to determine the effect of G-CSF (filgrastim) on platelet aggregation, specifically assessing arachidonic acid (AA)-induced platelet aggregation in healthy volunteers.", "results_summary": "Filgrastim significantly enhanced AA-induced platelet aggregation by 75% compared to placebo and baseline, indicating a strong pro-aggregatory effect. The study also noted increased platelet activation, measured by circulating soluble P-selectin, suggesting potential thrombotic risks.", "population_specificity": "78 healthy volunteers (randomized, placebo-controlled).", "effective_dosage": "5 \u03bcg/kg r-metHuG-CSF (filgrastim) subcutaneously for four days.", "study_duration": "Four days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:33.513016+00:00"}
{"study_id": 110858, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the optimal DHA concentration in infant formula for cognitive maturation, with all DHA-supplemented formulas containing 0.64% arachidonic acid (ARA).", "results_summary": "The study found no significant differences in cognitive outcomes between different DHA concentrations, but combining all DHA-supplemented groups showed higher cognitive scores compared to the control. ARA was included in all DHA-supplemented formulas but its independent effects were not isolated.", "population_specificity": "Infants aged 1-9 days at enrollment, followed until 18 months of age.", "effective_dosage": "0.64% ARA (consistent across all DHA-supplemented formulas).", "study_duration": "12 months of formula feeding, with cognitive assessment at 18 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.898310+00:00"}
{"study_id": 110860, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspirin failure (acute coronary syndrome despite aspirin use) is due to inadequate platelet inhibition by aspirin or reflects higher-risk patient profiles, with a focus on arachidonic acid-induced platelet aggregation.", "results_summary": "The study found that patients with aspirin failure had lower arachidonic acid-induced platelet aggregation after aspirin therapy compared to aspirin-naive patients, but this difference was not significant after adjusting for baseline characteristics. The results suggest aspirin failure is a marker of higher-risk profiles rather than inadequate platelet response to aspirin.", "population_specificity": "174 consecutive patients with acute myocardial infarction (118 aspirin-naive, 56 with aspirin failure).", "effective_dosage": "Not specified", "study_duration": "Platelet function analyzed after \u226572 hours of aspirin therapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:35.161229+00:00"}
{"study_id": 110859, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the associations between plasma PUFAs (including arachidonic acid) and metabolic/hormonal aspects of PCOS, and to investigate the efficacy of LC n-3 PUFA supplementation in modulating these effects.", "results_summary": "The study found that higher plasma n-6 PUFA concentrations (including arachidonic acid) were associated with elevated circulating androgens in PCOS. In bovine theca cells, arachidonic acid up-regulated androstenedione secretion, suggesting a role in steroidogenesis.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) (cross-sectional cohort n=104, intervention n=22) and primary bovine theca cells.", "effective_dosage": "Not specified for arachidonic acid.", "study_duration": "Not specified for arachidonic acid.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:35.459093+00:00"}
{"study_id": 110857, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ALOX5 gene variants influence eicosanoid production, including arachidonic acid-derived metabolites, in response to fish oil supplementation.", "results_summary": "The study found that arachidonic acid-derived metabolites (LTB4, LTD4, LTE4) did not vary by ALOX5 genotype, but other metabolites (5-HETE, 6-trans-LTB4, 5-oxo-ETE, 15-HETE, 5,15-diHETE) were higher in subjects with the \"55\" genotype. EPA- and DHA-derived metabolites showed genotype-dependent responses to supplementation.", "population_specificity": "116 subjects (68% female, 20-59 years old) of African American ancestry.", "effective_dosage": "5.0 g of fish oil daily (containing 2.0 g EPA and 1.0 g DHA) or placebo (5.0 g corn/soy mixture).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.373751+00:00"}
{"study_id": 110862, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to explore the relationship between vitamins and mast cells, particularly focusing on the role of arachidonic acid metabolites in mast cell inflammatory responses.", "results_summary": "The study highlighted that arachidonic acid metabolites are involved in the late phase of mast cell inflammatory responses, alongside de novo synthesis of cytokines and chemokines. Vitamins C and E were noted to have protective effects on immune cells, particularly in allergic diseases involving mast cells.", "population_specificity": "Not specified (general immune system context).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.852188+00:00"}
{"study_id": 110861, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of arachidonic acid in disease pathogenesis and therapy, particularly its imbalance with other fatty acids and its dietary influences.", "results_summary": "The study suggests that high dietary arachidonic acid, due to an unnaturally high omega-6/omega-3 ratio in animal products, exacerbates pain conditions, cardiovascular disease, and likely cancers. It proposes that reducing arachidonic acid and increasing omega-3 fatty acids in animal diets could improve health outcomes.", "population_specificity": "General population, with implications for dietary and agricultural practices.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:38.712464+00:00"}
{"study_id": 110863, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 75, "study_goal": "The researchers aimed to identify the best platelet function test to estimate aspirin-mediated platelet inhibition via arachidonic acid-inducible platelet reactivity in patients on dual antiplatelet therapy post-stent implantation.", "results_summary": "The study found poor correlation and agreement between five platelet function tests and urinary d-TXB2 levels, with only MEA showing a weak but significant correlation. Sensitivities and specificities for high residual platelet reactivity were low, suggesting current assays do not reliably mirror thromboxane inhibition.", "population_specificity": "225 patients on dual antiplatelet therapy after percutaneous intervention with stent implantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:41.791195+00:00"}
{"study_id": 110865, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between arachidonic acid (AA) levels and cognitive performance in schizophrenia patients, as well as the potential moderating role of dopamine.", "results_summary": "The study found that defects in AA signaling were associated with cognitive deficits in schizophrenia patients, and dopamine may moderate these relationships. Cognitive deficits, dopaminergic neurotransmission, and bioactive lipids appear to be interrelated features of schizophrenia.", "population_specificity": "Schizophrenia patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.162645+00:00"}
{"study_id": 110864, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the prevalence of poor response to aspirin therapy in PAD patients using arachidonic acid (AA) as one of the platelet function assays.", "results_summary": "The study found that 5% of PAD patients showed persistent poor response to aspirin when assessed using AA aggregation, with weak agreement between AA and other platelet function assays.", "population_specificity": "Patients with lower extremity peripheral arterial disease (PAD) on aspirin therapy.", "effective_dosage": "0.5 mg/mL of arachidonic acid (AA) for optical aggregation testing.", "study_duration": "6- to 12-month follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.301105+00:00"}
{"study_id": 110866, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of cyclooxygenase, particularly COX-2, in colorectal cancer chemoprevention, focusing on the conversion of arachidonic acid to prostaglandins.", "results_summary": "The study found that COX-2 overexpression is common in colorectal neoplasms, and NSAIDs, which inhibit COX-2, reduce the risk of colorectal adenoma and cancer by 40-50%. Arachidonic acid's role is primarily as a substrate for COX-2 in prostaglandin synthesis.", "population_specificity": "Individuals with colorectal neoplasms (adenomas or carcinomas) and those genetically predisposed (e.g., familial adenomatous polyposis or Lynch syndrome).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.609345+00:00"}
{"study_id": 110868, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the anti-inflammatory effects of arachidonic acid (\u03c9-6) with eicosapentaenoic acid (\u03c9-3) in reducing liver inflammation and damage in vitro.", "results_summary": "Arachidonic acid was less effective than eicosapentaenoic acid in reducing TNF-\u03b1 and IL-6 expression and did not significantly increase IL-10 expression in stimulated macrophages and hepatocytes.", "population_specificity": "Human macrophages and hepatocytes (THLE-3 cell line) in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:46.193294+00:00"}
{"study_id": 110867, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of dietary Atlantic salmon, rich in n-3 PUFAs including arachidonic acid, on disease activity in patients with mild ulcerative colitis.", "results_summary": "The study found that arachidonic acid levels in rectal biopsies correlated with histology and endoscopy scores, while n-3 PUFA levels and the n-3/n-6 ratio increased in plasma and biopsies. The anti-inflammatory fatty acid index (AIFAI) improved, accompanied by reduced clinical activity scores.", "population_specificity": "12 patients with mild ulcerative colitis", "effective_dosage": "600 grams of Atlantic salmon weekly", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:46.822139+00:00"}
{"study_id": 110869, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine the \"rebound\" phenomenon linked to clopidogrel cessation, including its effects on arachidonic acid pathways and potential prothrombotic/proinflammatory responses.", "results_summary": "The abstract suggests that clopidogrel withdrawal may trigger a prothrombotic or proinflammatory rebound effect, potentially influencing arachidonic acid pathways traditionally associated with aspirin. The study also highlights uncertainty about optimal clopidogrel therapy duration and its clinical implications.", "population_specificity": "Patients with acute coronary syndromes or those who underwent percutaneous coronary intervention.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:47.011373+00:00"}
{"study_id": 110870, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolites in endothelium-dependent contractions and their implications in vascular dysfunctions.", "results_summary": "The study found that arachidonic acid metabolites, generated by cyclooxygenase (COX), act as endothelium-derived contracting factors (EDCFs) and contribute to vascular dysfunctions in conditions like hypertension and diabetes. COX inhibition improved vasodilatations, but concerns about adverse cardiovascular effects of COX inhibitors were noted.", "population_specificity": "Animal models and patients with hypertension, metabolic diseases, or aging.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "COX inhibitors (e.g., indomethacin) and TP receptor antagonism were discussed, but no specific interactions with foods or supplements were mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.288976+00:00"}
{"study_id": 110871, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid, in regulating vascular tone, inflammation, and angiogenesis, and their therapeutic potential in vascular diseases.", "results_summary": "EETs function as endothelium-derived hyperpolarizing factors (EDHFs) to modulate vascular tone, attenuate inflammatory signaling, and regulate angiogenesis. Soluble epoxide hydrolase (sEH) inhibitors and potential GPCR targeting offer therapeutic avenues for vascular diseases like hypertension and atherosclerosis.", "population_specificity": "Vascular endothelium and vascular smooth muscle in models of vascular inflammation and angiogenesis (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:52.466244+00:00"}
{"study_id": 110875, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether iPLA(2)\u03b2, which releases arachidonic acid from phospholipids, plays a role in ER stress-induced \u03b2-cell apoptosis.", "results_summary": "The study found that iPLA(2)\u03b2 contributes to \u03b2-cell apoptosis through ceramide generation and mitochondrial abnormalities, linking ER stress and \u03b2-cell death in diabetes mellitus.", "population_specificity": "Pancreatic islet \u03b2-cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:53.719632+00:00"}
{"study_id": 110874, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the structural and functional properties of TREK-1 channels, including their activation by arachidonic acid.", "results_summary": "The study found that arachidonic acid augmented TREK-1 channel activation by tension, and this effect was retained even after deletion of an extracellular loop. Mutations in specific cysteines affected channel activity, but arachidonic acid's role in activation remained intact.", "population_specificity": "Mouse TREK-1 channels expressed in HEK-293T cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.932353+00:00"}
{"study_id": 110876, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the biological actions, therapeutic potential, and potential risks of electrophilic eicosanoids derived from arachidonic acid, focusing on their anti-inflammatory, anti-proliferative, and neurotoxic effects.", "results_summary": "The study found that electrophilic eicosanoids derived from arachidonic acid exhibit anti-inflammatory and anti-proliferative effects by modifying proteins in the NF-\u03baB pathway and redox-sensitive proteins, but they may also contribute to neurotoxicity and neurodegeneration through protein oligomerization or aggregation.", "population_specificity": "Not specified (biochemical and proteomic studies, likely in vitro or animal models)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:55.202683+00:00"}
{"study_id": 110873, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of desmopressin on platelet reactivity in patients undergoing cardiac surgery, using arachidonic acid as an agonist in platelet aggregometry.", "results_summary": "The study found that arachidonic acid-induced platelet reactivity decreased significantly in patients without antiplatelet therapy after extracorporeal circulation but recovered within 24 hours. In patients on ASA, platelet reactivity was not further reduced by extracorporeal circulation, and desmopressin did not significantly affect platelet reactivity.", "population_specificity": "86 patients undergoing elective coronary artery bypass grafting (CABG), including those with and without preoperative antiplatelet therapy.", "effective_dosage": "Arachidonic acid was used as an agonist in platelet aggregometry; specific dosage not provided.", "study_duration": "Perioperative period, with follow-up at 24 hours after protamine administration.", "interactions": "Interaction with acetylsalicylic acid (ASA) noted, but no significant effect of desmopressin on platelet reactivity was observed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:56.146045+00:00"}
{"study_id": 110877, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of tranexamic acid on arachidonic acid-induced platelet aggregation in patients on dual antiplatelet therapy versus those who ceased therapy.", "results_summary": "Tranexamic acid significantly increased arachidonic acid-induced platelet aggregation in patients on dual antiplatelet therapy but had no effect in those who had ceased therapy. The results suggest tranexamic acid may partially reverse platelet dysfunction caused by antiplatelet drugs.", "population_specificity": "40 patients scheduled for cardiac surgery (20 on dual antiplatelet therapy, 20 who ceased therapy for \u22657 days).", "effective_dosage": "2 g tranexamic acid (single dose).", "study_duration": "Single administration (blood collected 20 min before and after).", "interactions": "Dual antiplatelet therapy (aspirin and clopidogrel).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:00.447049+00:00"}
{"study_id": 110878, "supplement_id": 885, "safety_score": "30", "efficacy_score": 20, "quality_score": 50, "study_goal": "The researchers aimed to determine if oral \u03c9-3 fatty acid supplements (including fish oil) could be absorbed and incorporated into plasma fatty acids, and whether they could reduce markers of inflammation, particularly focusing on changes in arachidonic acid levels.", "results_summary": "The study found a reduction in arachidonic acid levels in phospholipids (P = 0.02), but no significant anti-inflammatory effects were observed. Modest increases in other \u03c9-3 fatty acids were noted, but these changes were insufficient to improve inflammatory markers.", "population_specificity": "Home-dwelling patients with chronic malabsorption dependent on parenteral nutrition.", "effective_dosage": "1.5 g of fish oil per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.135381+00:00"}
{"study_id": 110879, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to challenge the traditional view of COX-2 as the primary target for treating neuroinflammation and explore the roles of COX-1 and COX-2 in neuroinflammation and brain injury.", "results_summary": "The study found that COX-2 activity is linked to anti-inflammatory and neuroprotective effects, while COX-1 is involved in brain injury induced by pro-inflammatory stimuli, suggesting COX-1 inhibition as a potential therapeutic approach for neuroinflammatory diseases.", "population_specificity": "Not specified (focus on experimental data and review of neuroinflammation mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.830264+00:00"}
{"study_id": 110881, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived prostacyclin in treating pulmonary arterial hypertension and explore emerging therapies like gene and cell-based approaches.", "results_summary": "The study highlights prostacyclin as an effective vasodilator for pulmonary arterial hypertension but notes that current therapies have not significantly reduced mortality rates in the past 5 years, prompting the need for advanced treatments like prostacyclin synthase gene therapy and engineered stem cell therapies.", "population_specificity": "Patients with pulmonary arterial hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:02.571524+00:00"}
{"study_id": 110872, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pharmacokinetics, pharmacodynamics, clinical efficacy, and safety of epoprostenol, a prostacyclin analog derived from arachidonic acid, in treating severe pulmonary arterial hypertension (PAH).", "results_summary": "The study found that epoprostenol remains the first-choice therapy for severe PAH patients despite its short half-life and complex delivery system, with demonstrated clinical efficacy and safety compared to other prostacyclin analogs.", "population_specificity": "Severe pulmonary arterial hypertension (PAH) patients in WHO functional class IV.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.026678+00:00"}
{"study_id": 110855, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the use of arachidonic acid in platelet function testing and its role in monitoring antiplatelet therapy.", "results_summary": "The study found that arachidonic acid is used in platelet aggregometry to assess pharmacological inhibition of platelet function, but the technique lacks standardization. High residual platelet reactivity was associated with adverse cardiovascular events, but tailored antiplatelet therapy based on platelet function assessment remains unproven.", "population_specificity": "Patients at high risk for re-thrombosis or bleeding on antiplatelet therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.124673+00:00"}
{"study_id": 110882, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare n-3 PUFA levels, including arachidonic acid (AA), in plasma and platelet phospholipids between hemodialysis (HD) patients and subjects without kidney disease.", "results_summary": "The study found higher AA levels and AA/EPA ratios in platelet phospholipids of HD patients compared to healthy subjects, alongside lower EPA and DHA levels. These differences persisted after adjusting for gender, age, and dietary fish intake.", "population_specificity": "Hemodialysis (HD) patients and subjects without kidney disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.744356+00:00"}
{"study_id": 110880, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective properties of alpha-tocotrienol in attenuating arachidonic acid (AA) metabolism and neurodegeneration, particularly in brain tissue rich in polyunsaturated fatty acids.", "results_summary": "The study found that palm oil-derived alpha-tocotrienol at nanomolar concentrations effectively attenuated both enzymatic and nonenzymatic mediators of AA metabolism and neurodegeneration, demonstrating potent biological activity. This effect was noted in brain tissue with high PUFA content, particularly under pathologic conditions like acute ischemic stroke.", "population_specificity": "Brain tissue rich in polyunsaturated fatty acids, particularly in the context of neurodegenerative conditions such as acute ischemic stroke.", "effective_dosage": "Nanomolar concentrations (exact dosage not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.911599+00:00"}
{"study_id": 110884, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to examine the relationship between radiotherapy, oxidative damage, and arachidonic acid levels in patients with nasopharyngeal cancer.", "results_summary": "The study found that nasopharyngeal cancer was associated with elevated F(2)-isoprostanes in urine and plasma, but radiotherapy did not increase these levels and was associated with reductions in F(2)-IsoPs. Plasma esterified arachidonic acid residues were substantially lower in patients compared to controls.", "population_specificity": "Seven patients with nasopharyngeal cancer undergoing radiotherapy.", "effective_dosage": "Not specified", "study_duration": "Duration of radiotherapy treatment (not explicitly stated in abstract)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.344749+00:00"}
{"study_id": 110885, "supplement_id": 885, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of dietary restrictions in children with inborn errors of metabolism (IEM) on long-chain polyunsaturated fatty acids (LCPUFAs), including arachidonic acid, and evaluate the effects of LCPUFA supplementation.", "results_summary": "Observational studies found decreased LCPUFA status, particularly DHA, in IEM patients. LCPUFA supplementation effectively improved DHA status without detectable adverse reactions.", "population_specificity": "Children with inborn errors of metabolism (IEM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.608173+00:00"}
{"study_id": 110883, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine circulating levels of LTD4 (an arachidonic acid-derived lipid mediator) in hepatocellular carcinoma (HCC) patients and analyze its potential role in HCC pathogenesis.", "results_summary": "The study found significantly elevated circulating LTD4 levels in HCC patients compared to healthy subjects, suggesting a potential role in HCC pathogenesis, particularly in cases accompanied by chronic hepatitis B (CHB). However, LTD4 levels were not associated with tumor burden markers or inflammation factors, and no significant differences were observed between metastasis/non-metastasis or therapy/non-therapy groups.", "population_specificity": "Patients with hepatocellular carcinoma (HCC), including those with and without chronic hepatitis B (CHB).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:10.052625+00:00"}
{"study_id": 110888, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the dual roles of molecular oxygen in brain tissue\u2014supporting homeostatic glucose metabolism and contributing to pathogenic AA metabolism during stroke.", "results_summary": "The study highlights that AA, released during ischemic stroke, undergoes oxidative metabolism, producing biologically active metabolites that worsen stroke outcomes. It also discusses recent research on supplemental oxygen therapy as a potential intervention for stroke-related hypoxia.", "population_specificity": "Not specified (focus on ischemic stroke mechanisms in general).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:10.959397+00:00"}
{"study_id": 110886, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the physiological roles of prostanoids, metabolites of arachidonic acid, in allergic and immune diseases and discuss the clinical potential of receptor-selective drugs.", "results_summary": "The study found that prostanoid receptors have multiple, context-dependent functions, sometimes producing opposite effects, and their balance is crucial for homeostasis. It highlighted their roles in diseases like contact dermatitis, atopic dermatitis, asthma, rheumatoid arthritis, and encephalomyelitis.", "population_specificity": "Not specified (general review of prostanoid roles in immune and allergic diseases)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.099470+00:00"}
{"study_id": 110887, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to compare the hemostatic function of platelet concentrates treated with Mirasol PRT versus untreated controls, including assessing aggregation responses to arachidonic acid.", "results_summary": "PRT treatment reduced aggregation responses to arachidonic acid in stored platelet concentrates, though the effect was less pronounced compared to other agonists (p = 0.070). Addition of RBCs and plasma restored aggregation responses to levels comparable with untreated controls.", "population_specificity": "In vitro study using buffy coat platelet concentrates stored in platelet additive solution.", "effective_dosage": "Not specified", "study_duration": "Evaluated after 2, 3, 6, 7, and 8 days of storage.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:12.217009+00:00"}
{"study_id": 110889, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of aspirin (a COX inhibitor) on circulating endothelial progenitor cells (EPCs) and its potential implications for vascular repair, including responses to arachidonic acid stimulation.", "results_summary": "The study found that aspirin exposure reduced circulating EPCs, with no significant difference between 81 mg and 325 mg doses. Platelet aggregation in response to arachidonic acid and ADP was decreased in all patients, but endothelial function (BAFMD) remained unchanged.", "population_specificity": "32 subjects (primary and secondary prevention cohorts) randomly assigned to aspirin therapy.", "effective_dosage": "81 mg or 325 mg daily.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:12.575708+00:00"}
{"study_id": 110890, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid in the context of chronic inflammation and its potential contribution to metabolic syndromes and age-associated neuroendocrine disorders.", "results_summary": "The study suggests that increased arachidonic acid formation, as part of the prostaglandin and leukotriene cascade, may contribute to the development of metabolic syndromes and age-associated neuroendocrine disorders through pro-inflammatory and pro-oxidative effects. The abstract implies a link between arachidonic acid and chronic inflammation but does not provide direct experimental results.", "population_specificity": "The study discusses general mechanisms relevant to metabolic syndromes and age-associated neuroendocrine disorders, without specifying a particular study population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:13.753829+00:00"}
{"study_id": 110893, "supplement_id": 885, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of ARA supplementation on the composition of long-chain polyunsaturated fatty acids (LCPUFA) in the blood of young Japanese women.", "results_summary": "ARA supplementation increased ARA levels in all blood lipid fractions without reducing n-3LCPUFA levels, even at a low dose equivalent to one egg.", "population_specificity": "Young Japanese women (n=23)", "effective_dosage": "80 mg ARA daily (equivalent to one egg)", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:17.685466+00:00"}
{"study_id": 110891, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "To investigate the effect of arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation on cognitive functions in very low birth weight infants fed human milk.", "results_summary": "Supplementation showed positive effects on attention capacity but no significant difference in general cognitive functions (Bayley MDI and Ages and Stages Questionnaire). Plasma DHA concentration correlated with sustained attention and Bayley MDI scores.", "population_specificity": "Very low birth weight infants (<1500 g) fed human milk.", "effective_dosage": "31 mg AA per 100 mL milk, administered as 0.5 mL oil daily.", "study_duration": "From 1 week after birth until hospital discharge (average 9 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.297121+00:00"}
{"study_id": 110895, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of arachidonic acid metabolites in endothelial dysfunction and hypertension, exploring potential drug targets.", "results_summary": "The abstract highlights that arachidonic acid metabolites, including vasoconstrictor prostanoids, contribute to endothelial dysfunction and hypertension, suggesting these pathways as potential therapeutic targets.", "population_specificity": "Not specified (general discussion of endothelial cells and vascular mechanisms).", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.405825+00:00"}
{"study_id": 110894, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether EPA or DHA supplementation affects plasma F(2)-IsoPs and whether changes in plasma arachidonic acid influence these effects.", "results_summary": "EPA and DHA supplementation significantly reduced plasma F(2)-IsoPs in both studies, indicating reduced oxidant stress. The reduction was independent of changes in plasma arachidonic acid levels.", "population_specificity": "Overweight, dyslipidaemic men (Study A) and treated-hypertensive Type 2 diabetic patients (Study B).", "effective_dosage": "4 g daily of EPA or DHA.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:19.625661+00:00"}
{"study_id": 110896, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of targeting epoxyeicosatrienoic acids (EETs), derived from arachidonic acid, for cardiovascular diseases and hypertension.", "results_summary": "The study found that inhibiting soluble epoxide hydrolase (sEH) or using EET agonists reduced blood pressure, decreased inflammation, and improved vascular function in experimental models. These approaches also showed protective effects against organ damage associated with hypertension and metabolic syndrome.", "population_specificity": "Experimental animal models of hypertension and metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:20.347163+00:00"}
{"study_id": 110898, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review recent advances in eicosanoids, focusing on their structure, receptor biology, and pharmacological/clinical relevance.", "results_summary": "The abstract highlights the essential roles of eicosanoids in cellular homeostasis and disease states but does not provide specific findings on Arachidonic Acid's effects.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:20.710301+00:00"}
{"study_id": 110897, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid in PGE(2) biosynthesis and its implications for cancer cell proliferation and tumor development.", "results_summary": "The study found that arachidonic acid is converted to PGH(2) by cyclooxygenases (COX-1/2), which can then be isomerized to PGE(2) by MPGES-1, suggesting MPGES-1 as a potential therapeutic target for cancer. Several compounds targeting COX-2 or MPGES-1 also inhibit 5-lipoxygenase, which may benefit cancer treatment.", "population_specificity": "Cancer cells and tumors expressing MPGES-1.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:21.794350+00:00"}
{"study_id": 110899, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to understand the role of 5-lipoxygenase (5LO) in the biosynthesis of leukotrienes from arachidonic acid and its implications in inflammation, chronic diseases, and tumorigenesis.", "results_summary": "The study highlights that 5LO-derived leukotrienes from arachidonic acid play roles in normal host defense and contribute to chronic inflammatory diseases like asthma and atherosclerosis, with potential links to tumorigenesis.", "population_specificity": "Not specified (general biochemical and pathophysiological context)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:25.434643+00:00"}
{"study_id": 110900, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether arachidonic acid (AA) could inhibit hepatitis C virus RNA replication and modulate gene expression related to hepatic lipogenesis.", "results_summary": "Arachidonic acid, along with other PUFAs, was found to inhibit hepatitis C virus RNA replication and suppress hepatic lipogenesis by altering PPARa and SREBP gene expression, reducing triglyceride synthesis and accumulation.", "population_specificity": "Chronic hepatitis C patients and healthy subjects (1,084 patients vs. 2,326 controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:26.616869+00:00"}
{"study_id": 110901, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review ibuprofen-induced hypersensitivity syndrome and its clinical manifestations, focusing on the inhibition of arachidonic acid transformation by NSAIDs.", "results_summary": "The study highlights that ibuprofen, by inhibiting cyclooxygenase, impairs the transformation of arachidonic acid to prostaglandins, prostacyclin, and thromboxanes, which can lead to hypersensitivity syndrome in susceptible individuals. The reaction is idiosyncratic, involving metabolic and immunologic factors, and presents with fever, rash, and internal organ involvement.", "population_specificity": "Susceptible individuals experiencing hypersensitivity reactions to ibuprofen.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:27.657005+00:00"}
{"study_id": 110902, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms of action of diclofenac, including its effects on arachidonic acid release and uptake, and compare its pharmacologic properties with other NSAIDs.", "results_summary": "The study found that diclofenac can affect arachidonic acid release and uptake, among other mechanisms, but noted that further research is needed to confirm if these pathways translate to clinical benefits.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:27.721827+00:00"}
{"study_id": 110904, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether normalizing ASPI-test results using TRAP-test results could improve the classification of ASA responders and non-responders in patients with reduced platelet activatability.", "results_summary": "The study found that normalizing ASPI-test results with TRAP-test results provided a more valid discrimination between ASA responders and non-responders, particularly in patients with decreased platelet activatability, despite pre-analytical factors affecting measured results.", "population_specificity": "ASA-treated volunteers and controls (healthy volunteers and cardiac patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:28.931448+00:00"}
{"study_id": 110903, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether arachidonic acid (AA) levels differed between depressive patients and control subjects, as part of investigating the phospholipid hypothesis of depression.", "results_summary": "The study found no significant change in AA levels between depressive patients and control subjects, unlike the observed reductions in omega-3 polyunsaturated fatty acids (EPA and DHA). This suggests AA may not play a direct role in the pathogenesis of depression.", "population_specificity": "Depressive patients and control subjects.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:29.170331+00:00"}
{"study_id": 110892, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of arachidonic acid-derived epoxyeicosatrienoic acids (EETs) in pulmonary vasoconstriction and hypoxia response, and their potential therapeutic implications for pulmonary hypertension.", "results_summary": "The study found that 11,12-EET, derived from arachidonic acid, potentiates pulmonary vasoconstriction by recruiting TRPC6 channels, and inhibiting its breakdown enhances hypoxia response. The pathway involving cytochrome P450 enzymes and soluble epoxide hydrolase is implicated in vascular remodeling in chronic hypoxia and pulmonary hypertension.", "population_specificity": "Not specified (likely animal models, given the mention of TRPC6 knockout mice).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:29.468369+00:00"}
{"study_id": 110905, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of arachidonic acid-derived epoxyeicosatrienoic acids (EETs) and the effects of soluble epoxide hydrolase (sEH) inhibition on cardiovascular diseases, including heart failure, cardiac hypertrophy, and ischemia/reperfusion injury.", "results_summary": "The study found that sEH inhibition, which increases endogenous EETs derived from arachidonic acid, effectively prevented and reversed cardiac hypertrophy, reduced infarct size, and prevented cardiac remodeling and arrhythmias in animal models of cardiovascular disease.", "population_specificity": "Animal models (e.g., hypertension, cardiac hypertrophy, ischemia/reperfusion injury)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:30.948577+00:00"}
{"study_id": 110906, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the variation in milk fatty acids, including arachidonic acid (AA), in mothers of preterm infants and assess the impact of tuna oil supplementation on AA and DHA levels.", "results_summary": "The study found no significant difference in AA levels between supplemented and control groups, with AA ranging between 0.2-0.9% in both. The AA:DHA ratio was wider in control mothers' milk compared to supplemented mothers, suggesting variability in natural milk composition.", "population_specificity": "Mothers of preterm infants.", "effective_dosage": "Not specified (tuna oil supplementation details not provided).", "study_duration": "Milk samples were collected every 2 weeks while infants were hospitalized (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:35.119517+00:00"}
{"study_id": 110907, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites in modulating Wallerian degeneration and potential therapeutic interventions.", "results_summary": "The abstract suggests arachidonic acid metabolites are involved in modulating Wallerian degeneration, but their exact role in axonal degeneration and regeneration remains unclear. The study reviews existing evidence but does not provide definitive conclusions on efficacy.", "population_specificity": "Not specified (general discussion of molecular processes in peripheral nerve injury).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:35.307782+00:00"}
{"study_id": 110909, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether omega-3 polyunsaturated fatty acids could enhance platelet inhibition in patients on standard dual antiplatelet therapy (aspirin and clopidogrel) after PCI, using arachidonic acid as an agonist in platelet function tests.", "results_summary": "The study found that omega-3 fatty acids significantly enhanced platelet response to clopidogrel but did not significantly alter platelet aggregation after arachidonic acid stimulation, which remained low throughout the study. No cases of aspirin resistance were observed, indicating good medication compliance.", "population_specificity": "Stable coronary artery disease patients undergoing percutaneous coronary intervention (PCI).", "effective_dosage": "1 g of omega-3 ethyl esters daily.", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:37.072842+00:00"}
{"study_id": 110908, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether flax oil supplementation, which affects arachidonic acid (AA) levels, could safely reduce symptom severity in youth with bipolar disorder.", "results_summary": "Higher serum arachidonic acid (AA) levels were positively correlated with increased clinician-rated Global Symptom Severity, suggesting AA may worsen symptoms in bipolar disorder. Flax oil supplementation did not significantly alter primary outcomes but showed potential benefits when EPA levels increased and AA levels decreased.", "population_specificity": "Children and adolescents aged 6-17 years with symptomatic bipolar I or bipolar II disorder.", "effective_dosage": "Flax oil capsules containing 550 mg alpha-LNA per 1 gram, titrated up to 12 capsules per day.", "study_duration": "16 weeks (mean treatment duration was 11.8 weeks for alpha-LNA group).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:37.995242+00:00"}
{"study_id": 110912, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to clarify the role of prostaglandins, derived from arachidonic acid, in the immunopathology and potential treatment of multiple sclerosis (MS).", "results_summary": "The study suggests that prostaglandins, as arachidonic acid-derived mediators, play a role in inflammation associated with MS, and modulating their receptors could be a potential therapeutic approach.", "population_specificity": "Patients with multiple sclerosis (MS) or related inflammatory CNS conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:39.257181+00:00"}
{"study_id": 110910, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether platelet hyporesponsiveness to acetylsalicylic acid (ASA) could be transferred via a plasma factor, using arachidonic acid (ARA) to measure platelet aggregation.", "results_summary": "The study found that plasma from ASA-hyporesponsive patients could transfer hyporesponsiveness to normal platelets, resulting in full ARA-induced aggregation (81%) that was not inhibited by ASA. In contrast, plasma from ASA-responsive patients maintained nearly complete inhibition of ARA-induced aggregation (7% after ASA addition).", "population_specificity": "80 patients who had undergone coronary bypass surgery and a group of healthy volunteers.", "effective_dosage": "1 mmol/l ARA for platelet aggregation testing; 25 micromol/l ASA in vitro.", "study_duration": "Not specified.", "interactions": "Interaction with ASA (aspirin) was noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:39.745879+00:00"}
{"study_id": 110911, "supplement_id": 885, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess whether astaxanthine (derived from Xancor) affects human biomarkers of hemostasis, including platelet function, coagulation, and fibrinolysis, particularly in relation to arachidonic acid-induced platelet aggregation.", "results_summary": "The study found that astaxanthine did not affect platelet aggregation induced by arachidonic acid, nor did it alter coagulation or fibrinolytic indices in both aspirin-na\u00efve and aspirin-treated subjects. No significant changes were observed across various concentrations of astaxanthine.", "population_specificity": "12 aspirin-na\u00efve and eight aspirin-treated volunteers with multiple risk factors for vascular disease.", "effective_dosage": "Escalating concentrations (0.3 \u00b5M, 1 \u00b5M, 3 \u00b5M, 10 \u00b5M, 30 \u00b5M, and 100 \u00b5M).", "study_duration": "Not specified (in vitro study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:39.814271+00:00"}
{"study_id": 110913, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether inhibiting the 5-lipoxygenase pathway of arachidonic acid (thereby reducing leukotriene production) would affect cardiac conduction system function during coronary procedures.", "results_summary": "Inhibition of 5-lipoxygenase reduced urinary leukotriene E(4) by 26%, decreased heart rate by 7%, improved heart rate variability, and protected against procedure-induced conduction disturbances, but had no effect on arrhythmias or ischemic ECG patterns.", "population_specificity": "Patients with stable angina undergoing elective coronary catheterization or angioplasty.", "effective_dosage": "Not specified", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:41.218323+00:00"}
{"study_id": 114326, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of bariatric surgery in improving symptoms and metabolic conditions in obese patients with polycystic ovary syndrome (PCOS).", "results_summary": "Bariatric surgery significantly reduced abnormal menstruation, hirsutism, serum testosterone levels, body mass index, and the prevalence of type 2 diabetes and hypertension in obese PCOS patients.", "population_specificity": "Obese patients with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:48.817185+00:00"}
